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Abstract 
 
Tricarbonyl(ŋ5-carboxylic acid methyl ester)iron(1+) hexafluorophosphate(1−) (97) was 
easily prepared in a moderate yield by a tandem Wittig-Michael addition using (3-
methoxycarbonylallyl)triphenylphosphonium bromide (94). The resulting cyclohexa-1,3-
dienecarboxylic acid methyl ester (95) was complexed with Fe2(CO)9 to obtain 
tricarbonyl(cyclohexa-1,3-dienecarboxylic acid methyl ester)iron(0) (96) was converted into 
the highly electrophilic tricarbonyl(ŋ5 -carboxylic acid methyl ester)iron(1+) 
hexafluorophosphate(1−) by hydride abstraction using triphenylcarbenium 
hexafluorophosphate (97). 
4-Bromo-1,2-(methylenedioxy)benzene (132), 6-bromopiperonylic acid (98) and 2-bromo-5-
methoxy benzoic acid (140)  were converted into aryllithium reagents through lithium-
bromide exchange by treatment with n-butyllithium. Lithiation and deuteration of 6-
bromopiperonylic acid (98) , 2-bromobenzoic acid (136) and of 2-bromo-5-methoxybenzoic 
acid (140) were investigated by using various reagents such as n-butyllithium, LiHMDS and 
NaH to find the best route for the arylation of 98 to go onwards our target (+/−)-
hippeastrine (107 and 108). 
Tricarbonyl[ŋ4-1-methyl ester-5-(3',4'-methylenedioxy)phenylcyclohexa- 1,3-diene]iron(0) 
(134) was prepared by preparing the aryllithium reagent 132 by lithium-bromide exchange 
and converting it into an organocuprate nucleophile with copper(I) bromide. Arylation with 
the cation 97 resulted in the formation of the complex 134. Tricarbonyl[ŋ4-1-methyl ester-5-
(3',4'-methylenedioxy-6'-carboxyphenyl)cyclohexa- 1,3-diene]iron(0) (99) was synthesised in 
the same way as complex (134), using the lithiated 6-bromopiperonylic acid (98) as the 
reagent. The structures of the compounds were determined by IR, 1H-NMR, 13C-NMR 
spectroscopy and mass spectrometry.  
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1.Introduction  
Natural products have been a source of novel active compounds for many decades and have 
been used as lead molecules as well as scaffolds for elaboration of a great many potent 
drugs for the treatment of various diseases.1 Classical natural product examples are found 
among anticancer (e.g. paclitaxel also known as Taxol derived from yew bark tree)2, 
antiparasitic (e.g. artemisinin isolated from a Chinese herb called sweet wormwood that is 
used as a lead compound for antimalarial treatment)3 and antibacterial drugs (e.g. 
fosfomycin trometamol, also known as Monuril, which is an antibiotic used to treat acute 
uncomplicated urinary tract infections). Alkaloids are nitrogen containing natural products 
with low molecular weight and are widely found in nature, most often in plants and have 
interesting pharmacological properties. The biological activity of many alkaloids often relies 
on the amine being transformed into a quaternary ammonium ion, by protonation at 
physiological pH values.4                                                                                                                                               
Hippeastrine, is a member of the alkaloid family and possesses numerous pharmacological 
properties. From a purely synthetic point of view, hippeastrine possesses key structural 
elements that make it an attractive challenge for synthetic organic chemists due to the 
number of synthetic approaches that can be envisaged. The structural properties and 
synthetic strategies will be explained and developed later on in this chapter. This project 
aims towards the synthesis of hippeastrine (for which a model study has already been 
achieved by Stephenson's group5), taking advantage of the available tricarbonyl iron and 
organo cuprate chemistry in order to build hippeastrine's A,B,C ring model system (Figure 
1). 
 
Figure 1: Hippeastrine 
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1.1. History of Alkaloids  
Alkaloids are compounds that are widely occurring in nature and are typically extracted 
from plants but can also be found in other organisms. Some frogs for example produce toxic 
alkaloids in the skin or secretory glands, and insects such as ants use alkaloids as 
pheromones. Fungi are also a source of alkaloids.6 These living organisms have over 
thousands of years developed the production of alkaloids as defences against herbivores, 
carnivores, microorganisms or viruses and hence have developed alkaloids exhibiting a wide 
range of properties.7 The first evidence that humankind used alkaloid-producing plants was 
described in Assyrian clay tablet written in cuneiform characters four thousand years ago. 
These tablets described about 250 different plants including a number of alkaloid- 
containing plants such as Papaver somnifirum known as opium poppy and Atropa 
belladonna known as deadly nightshade.7 The term alkaloid was coined by the German Carl 
Friedrich Wilhelm Meissner in 1819 to refer to plant natural products showing basic 
properties similar to those of the inorganic alkalis.8 The first isolation of an alkaloid was 
achieved by French apothecary Derosne in 18039 who isolated narcotine (Figure 2), before 
Sertürner further investigated alkaloids by isolating opium9 (Figure 3) in 1806 and morphine 
(Figure 3) in 1816. Other alkaloids such as strychnine (1817), emetine (1817), brucine 
(1819), piperine (1819), caffeine (1819), quinine (1820), colchicine (1820) and coniine (1826) 
were isolated by Pelletier and Caventou.9 Coniine was the first alkaloid to have its structure 
established by Schiff in 1870 and to be synthesized by Ladenburg in 1889.9 
             
O
O N
O
MeO
OMe
O
H
OMe
H
1                                                                                     
           Figure 2: Narcotine Structure                                                 Figure 3: Opium and morphine Structure                 
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1.2. Amaryllidaceae Alkaloids  
Around 12,000 different alkaloids distributed over a number of distinct classes have been 
identified in plants, and many of them possess potent effects in the treatment of several 
human medical conditions. The Amaryllidaceae produce a class of alkaloids that is notably 
occuring in a range of families of bulbous plants: Galanthus (snowdrops), Narcissus 
(daffodils) genera and many other bulbous species.10 Amarylladiceae is composed of around 
1100 species in circa 85 genera that are widely distributed throughout the tropics and warm 
temperate regions of the world.  These alkaloids form a unique class of nitrogen-containing 
compound showing promising biological activities such as galanthamine (commercially 
known as Reminyl), an acetylcholinoesterase inhibitor used in the treatment of Alzheimer's 
disease11 and lycorine that shows antiinflamatory12 as well as antimalarial properties.13 
Lycorine, amarbellisine, haemanthamine and haemanthidine also exhibit important activity 
against apoptosis-resistance on six different cancer cell lines.14 Pancratistatin and 
narciclasine have also been shown to possess promising antitumor activity.15 The 
Amaryllidaceae alkaloids are classified according to their main skeletal structure and named 
after a representative alkaloid from each class.  They are classified into nine main 
subgroups.10 
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Scheme 1: The Amaryllidaceae alkaloid family subgroups 
1.3. Function and Synthesis of the Alkaloid Hippeastrine  
The homolycorenine-type hippeastrine, an alkaloid from the Amaryllidaceae family is 
isolated from genera such as Brunsvigia, Crinum, Boophane or the genus Pancratium which 
contains over 21 species distributed around the Mediterranean region.16 Pancratium 
canariense, a white bulbous flower usually found in Canary Islands, is the main source of 
hippeastrine. In 2009, Cedrón's group was the first group to investigate and extract 
hippeastrine (1.35 g) among other amaryllidaceae alkaloids from Pancratium canariense.17  
Hippeastrine possesses some potent biological activities, Evidente et al.18 tested the 
anticancer activity of hippeastrine and other Amaryllidaceae alkaloids and concluded that 
hippeastrine has antiproliferative activities and inhibits cell growth in vitro at nontoxic 
concentrations. It was also found to display antiviral activity against Herpes simplex virus 
(HSV) type 1 due to the hexahydrolindole ring which has a direct effect on virus 
multiplication,19 and antifungal activity against Candida albicans a fungus responsible for 
unpleasant symptoms such as athlete’s foot and thrush for humankind.20  Modifications 
performed on hippeastrine 13  gave a series of analogues which were tested for their potent 
antimalarial activity and it was found that the hippeastrine derivative that lacked the 
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methylenedioxy moiety 14 showed a slight increase in activity compared to the parent 
molecule 13. The activity of the different dimers (15, 16, 17, 18) of hippeastrine showed a 
10-fold increase compared to hippeastrine (13). The fact that the dimers are more potent 
than the monomers could suggest an improvement of the dimers' binding to the specific 
target or potential hydrolysis of the dimer giving two molecule of hippeastrine during the 
biological outcome.21 
 
Scheme 2: Antimalarial activity (in μM) of hipeastrine analogues 
Hippeastrine (13) possesses several structural key elements: four stereogenic centres, a 
methylenedioxy group and a lactone ring B. The hydroxyl in the C ring and the tertiary amine 
in the 5-membered D ring are orientated cis to each other, whilst being trans to the two 
bonds connecting rings B and C (Figure 1).  
1.3.1. Synthesis of Hippeastrine  
Two major groups have synthesised hippeastrine, Kotera's and Katakawa's. In 1967, Kotera 
et al. reported22 the synthesis of hippeastrine (13) from diacetyllycorine (19) in seven steps 
(scheme 3). The von Braun degradation performed on the diacetyllycorine with cyanogen 
bromide in dry toluene afforded two products 20 and 21 (detectable in equal intensity as 
poorly isolable spots on TLC plate) obtained in 100% yield. They differed by a rotation of 21 
around the single bond between ring A and C was performed. Subsequent treatment of 21 
with 5% ethanolic potassium hydroxide at room temperature allowed the ring closure to 
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occur giving 22 (formation of ring B) in 31% yield. Refluxing 22 with aqueous HCl (3%) 
afforded the secondary amine 23 in 36% yield. An Eischweiler-Clark reaction installed the N-
methyl group on the secondary amine by reflux of 23 with formic acid and formaldehyde 
giving compound 24 in 87% yield. Acetylation of deoxyhippeastrine 24 was achieved using 
acetic anhydride and pyridine to give the crude acetate 25 (95% yield) which in turn was 
reacted with chromium trioxide in dry pyridine afford 26 in 13% yield. Finally, the desired 
compound 13 was obtained by reflux with 5% potassium bicarbonate in methanol (91% 
yield).  
 
Scheme 3: Synthesis of Hippeastrine from diacetyllycorine  
 
In 1984, Katakawa and Meguri suggested a synthetic route of (±)-hippeastrine (Scheme 4).23 
The starting material urethane-ester 27 was previously used as a starting material in the 
total synthesis of the Amaryllidaceae alkaloids, lycorine and zephyranthine.24 In this case, 
urethane-ester 27 was treated with sodium hydroxide yielding the amino acid sodium salt 
28 that was then treated with concentrated HCl and DCC to form the 5-membered ring (29, 
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80% yield) which eventually becomes the D ring of hippeastrine. The next step involved the 
methylation of the amine in the five-membered ring affording 30 in good yield, followed by 
the electrophilic alkylation of the aromatic A ring using chloromethyl methyl ether to give 
the acetoxy-lactam 31 (45% yield). Epoxidation of the double bond in the C ring with m- 
chloroperbenzoic acid in methylene chloride gave 32 as the sole product in 75% yield. 
Reaction of the epoxide with acetic acid and acetic anhydride in the presence of boron 
trifluoride etherate effected ring opening and the formation of a triacetate 33 in good yield. 
Alkaline hydrolysis of the triacetate in ethanol yielded to a triol 34, and was followed by 
cyclisation (formation of the lactone ring B) affording 35. 35 was treated with 
methanesulfonyl chloride in pyridine giving mesylate 36 which was in turn reacted with 
lithium chloride and lithium carbonate in dimethyl formamide under anhydrous conditions 
to yield the dehydro-lactam 37 (85% yield). Epoxidation of the alkene gave compound 38 
(80% yield), and conversion of the epoxide into an allylic alcohol using Sharpless conditions25 
afforded 39 (45% yield). Acetate protection of the allylic alcohol gave 40 which was then 
treated with trimethyloxonium tetrafluoroborate first, followed by zinc borohydride in order 
to reduce the lactam to the tertiary amine ring D, giving 41 in 13% yield. Hydrolysis of the 
acetate with potassium carbonate in methanol/water afforded (±)-hippeastrine (13). 
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Scheme 4: Synthesis of the racemic (±)-hippeastrine  
 
1.4. Importance of tricarbonyliron complexes in the synthesis of Alkaloids  
Tricarbonyl iron complexes are of high interest in asymmetric synthesis, in particular as 
precursors to chiral cationic iron complexes. These relatively stable complexes are also 
important intermediates for the synthesis of fairly complex natural products.26 Cationic 
tricarbonyliron moieties react notably with a versatile range of nucleophiles to form new 
stereogenic centre(s). Moderate to good control of the regioselectivity and complete control 
of stereoselectivity in this reaction process can be achieved, providing a general access to 
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specific enantiopure diastereoisomers by varying the nature and the position of the 
substituents attached to the cationic tricarbonyliron complex.27 Cyclohexadienyliron 
complexes are thus convenient building blocks for the synthesis of alkaloids. They can be 
reacted with several aryl moieties, creating a new carbon-carbon bond, and forming the 
backbone of many alkaloids, often referred to as the "C12 central building block".28 
   
      
Figure 4:  Simple example of "C12 building block"  
A second nucleophile addition can be used, forming a second carbon carbon bond and in 
some cases creating quaternary stereogenic centres is possible in this way. In this step, the 
nature and position of the aryl substituent and other functional groups that are present in 
the cyclohexadienyliron affect the regiocontrol.29 When both reactions take place at the 
same position, this is referred as “1,1 iterative series”; O-methyljoubertiamine and 
mesembrine are such examples of alkaloids demonstrating this pattern. Reactions at 
adjacent positions are referred to as “1,2 iterative series”; hippeastrine and lycorine are 
examples that display this series.30 
 
                                                                    
Figure 5: 1,1 iterative series illustrated by O- methyljoubertiamine                 Figure 6: 1,2 iterative series illustrated by                
hippeastrine                           
1.4.1. Preparation of tricarbonyliron complexes 
In 1930, Reihlen's group was the first group to report the successful synthesis of a metal-
diene transition complex. Using an excess of 1,3-butadiene with pentacarbonyliron in an 
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autoclave for 24 hours at 135-140 ◦C, he formed tricarbonyl (ƞ4-buta-1,3-diene)iron in 15% 
yield.31 Then in 1958, Pauson and Hallam synthesised for the first time a tricarbonyl(ƞ4-
cyclohexadiene)iron complex in 21% yield, using the original procedure of Reilhen.32 Since 
then, the traditional procedures to prepare tricarbonyliron-diene complexes are performed 
by direct complexation of 1,3-dienes with carbonyliron compounds (pentacarbonyliron, 
nonacarbonyldiiron, or dodecacarbonyltriiron) under either thermal or photolytic conditions 
that generate the loss of one or more carbon monoxide molecules.33 
 
 
Scheme 5: synthesis of tricarbonyl(ƞ4-cyclohexadiene)iron by thermal or photolytic conditions using different 
carbonyliron compounds 
 
1.4.2. Ligand exchange using transfer reagents. 
The complexation of the diene to the metal fragment can be achieved under milder reaction 
conditions and thus leading to a greater selectivity using tricarbonyliron transfer reagents.33 
These compounds are labile complexes in which the ligand exhibits only a relatively weak 
coordination to the iron.34   The development of such tricarbonyliron transfer reagents for 
the efficient complexation of 1,3-dienes has been largely investigated over the past 
decades. Weiss' group reported the first synthesis of tricarbonyl-(η4-1-oxabuta-1,3-
diene)iron complexes in 1964 using this method.35  Among these complexes 
tricarbonyl(cinnamaldehyde)iron was prepared by heating 
tetracarbonyl(cinnamaldehyde)iron at 60 °C for 15 hours. These complexes were used as  
tricarbonyliron transfer reagents for the first time by Lewis in 1972.33 The (η4- 
benzylideneacetone)tricarbonyliron complex, (bda)Fe(CO)3, an example of tricarbonyl-(η4-1-
oxabuta-1,3-diene)iron complex, was obtained in 32% yield by Lewis' group using thermal 
reaction conditions (heating for 4-5 hours at 60 ◦C in toluene) by reacting 
benzylideneacetone with diironnonacarbonyl.36 In 1991, Thomas' group improved the 
method by refluxing for 18 hours benzylideneacetone and two equivalents of 
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diironnonacarbonyl in diethyl ether obtaining 81% of the desired compound.37 Cyclohexa-
1,3-diene reacts with (bda)Fe(CO)3 in benzene to produce the tricarbonyl(ƞ4-
cyclohexadiene)iron in almost quantitave yield.38 This reaction clearly demonstrates the 
utility of such tricarbonyliron transfer reagents, as they give the desired triironcarbonyl 
complexes in much higher yield than the traditional method.
 
Scheme 6: Mechanism for the transfer of the tricarbonyliron fragment from (η4- benzylideneacetone)tricarbonyliron to 
cyclohexa-1,3-diene  
 
When increasing the reaction temperature, complex 45 undergoes a haptotropic 
rearrangement to form (η2- benzylideneacetone)tricarbonyliron (46). Coordination of the 
iron atom to one of the double bonds of cyclohexa-1,3-diene (43) forms (η2-
benzylideneacetone)tricarbonyl(η2-cyclohexa-1,3-diene)iron (47). This complex is very 
unstable and generates the loss of benzylideneacetone (48) to yield tricarbonyl(η2-
cyclohexa-1,3-diene)iron (49) followed by another haptotropic migration to produce the 
desired tricarbonyl(η4-cyclohexa-1,3-diene)iron complex (44).  In 1967, Otsuka 39 followed 
by Lewis in 197240 described for the first time (η4-1-azabuta-1,3-diene)tricarbonyliron 
complexes as a novel class of transfer reagents due to their great stability in air and their 
greater lability. These useful tricarbonyliron transfer reagents are usually easily prepared in 
high yield by condensation of cinnamaldehyde (50) and the amino compound 51 to result in 
the formation 1-azabuta-1,3-dienes 52. Sonication of the 1-azabuta-1,3-dienes 52 in the 
presence of nonacarbonyldiiron gives transfer reagent 53 which can then reacts with 
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cyclohexa-1,3-diene (43) at high temperature to achieve the transfer of the metal fragment 
and provide the tricarbonyliron cyclohexa-1,3-diene complexes (44) in excellent yields.41                
 
Ph O R NH2 Ph N
R
Ph N R
Fe(CO)3
H2O
Fe2CO9, THF
ultrasound, 25 oC, 15-18 h
50 51 52 53
43
THF, 65 oC, 2-4 h
Fe(CO)3Ph N
R
52 44  
Scheme 7: Synthesis of tricarbonyl(η4- cyclohexa-1,3-diene)iron from azabuta-1,3-dienes  
 
1.4.3 Hydride abstraction 
 In 1960, Fischer presented for the first time the hydride abstraction of a triironcarbonyl 
complex, (scheme 8, 44). Addition of triphenylcarbenium tetrafluoroborate (Ph3CBF4) to 
complex 44 resulted in the removal of a hydride ion subsequently affording tricarbonyl(η5-
cyclohexadienylium)iron tetrafluoroborate (54).42 
Fe(CO)3
PH3C BF4
Fe(CO)3
BF4
44 54  
Scheme 8: Hydride abstraction of tricarbonyl(η4-cyclohexa-1,3-diene)iron complex 
 
Hydride abstraction from substituted cyclohexadiene complexes has been extensively 
examined by Birch's group, commencing in 1973. Different regioisomers were obtained in 
various ratios and these ratios were found to depend on the steric demand, electronic 
properties and position of the substituent groups on the diene and surrounding the 
hydrogen atom that needed to be removed.43 
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Scheme 9: Hydride abstraction sites  
entry R Ratio 55:56 
1 H 80:20 
2 Me 90:10 
Table 1 :  Ratio of different substituted tricarbonyl(η5-cyclohexadienylium)iron tetrafluoroborate 
 
In this example (scheme 9, table 1), the hydride abstraction was favoured at C-5 position 
due to the electron donating nature of the -OMe substituent.  
In an alternative approach, 1- and 2-methoxycyclohexa-1,3-diene complexes 57 and 58 were 
converted into the carbonium salt (62) by treatment with concentrated sulfuric acid, 
followed by ether washes and addition of 10% ammonium hexafluorophosphate.44 
 
Scheme 10: Conversion of 1- and 2-methoxycyclohexa-1,3-diene complexes into methyl-substituted tricarbonyl(η5-
cyclohexadienylium)iron salts be demethoxylation using concentratred sulfuric acid  
 
Equilibration of 1- and 2-methoxycyclohexa-1,3-diene or protonotion at the least hindered 
position of those complexes would result in the formation of the π-allyl complexes (59) and 
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the acyclic π-allyl complexes (60) which was reported by Pettit and Emmerson in 1962 by a 
simple water attack .45 60  that contains -CHOMe allylic group onto the complexed diene, 
goes through methanolysis process to protonate OMe, which would give (62). The last 
reaction is irreversible under the conditions. The final step led to the formation of stable 
carbonium salts in strongly acid media.  
1.5. Organocopper reagents  
Organocopper reagents provide a general synthetic tool in organic chemistry for carbon-
carbon bond formation. Indeed, they readily react with α,β-unsaturated carbonyl 
compounds via conjugate addition in a 1,4-manner or alternatively they can react via 
nucleophilic substitution of various groups, epoxide opening  and additions to acetylenes.46    
The first organocoppper reagent was investigated in 1923 by Reich who synthesised 
unstable phenylcuprate which was prepared from phenyl-magnesium bromide and cuprous 
iodide.47 Then, in 1952, Gilman's group obtained organocopper reagents by transmetalation 
of organolithium reagents with copper(I) halides. The reactions with organolithium reagents 
generally require a stoichiometric amount of copper salt (one equivalent of copper reagent 
for two equivalents of lithium reagent), so no free organolithium reagent remains, since the 
lithium reagent itself is very reactive toward most substrates.48 Organomagnesium, 
organozinc and organoboron compounds can also be transmetalated.  
 
Scheme 11: Gilman reagent reaction equation  
 
In 1967, Corey and Posner showed that organocopper reagents could be used efficiently for 
carbon-carbon σ bond formation. Reaction between organic halides and Gilman reagent 
such as lithium dimethylcopper gave a new carbon-carbon σ bond by displacement of the 
halide.49 
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1.5.1. High order and low order organocuprates 
Organocuprates are important well established synthetic tools in organic chemistry. They 
have been used in the synthesis of many natural products such as prostaglandin E2 through 
a tandem organocopper conjugate addition/alkylation reaction.50 The synthesis of O-
methyljoubertiamine and lycoramine have also shown the use of organocopper reagents to 
provide "C12 central building block".27 Depending on the stoichiometric amount of 
organolithium reagent LiR (one or two equivalents) added to CuX ( X= I, Br, Cl, CN, etc...), 
two different type of organocuprates can be formed, RCu(X)Li (i.e. the Gilman Reagent) and 
R2Cu(X)Li2, respectively. The term ‘‘higher-order’’ (R2Cu(X)Li2) organocuprates was 
introduced for the first time in 1984 by Lipshutz et al. "High-order cyanocuprate" proved to 
have a greater reactivity, selectivity and often give better yield than the corresponding 
"lower order" form.51 
                                                                    
                         Figure 7a                                                                                               Figure 7b 
       
Lipshutz considered the idea that Cu(I) salts are tricoordinated (Figure 7a). This was the 
cause of a controversy in the 1990s, as the research community was wondering whether to 
accept the "higher-order" cyanocuprate concept or not. Many research groups, however, 
have subsequently confirmed its legitimacy and suggested that the nitrile ligand would be 
unbound to copper. However, adressing a question raised by Lipshutz: "If the nitrile group is 
not bounded to the copper, then where is it ?"52, Bertz et al., using  1H, 13C NMR data, 
showed that the 13C chemical shifts from phenyl, alkyl, methyl moieties prepared from two 
equivalents of RLi with one equivalent of CuCN or CuI in THF were similar. MeCuLi.LiCN 
shows a 13C chemical shift for the methyl group at − 9.51 ppm and the corresponding signal 
for MeCuLi.Lil is found at − 9.62 ppm.53 Futhermore, the CN resonances for R2Cu(CN)Li2 
(where R= Ph, Et, Me) were identical, whereas in "lower-order cyanocuprates" (one  
equivalent of RLi and one equivalent of CuCN), clear changes in the CN chemical shift are 
observed when the R group is varies.53 Snyder and Penner-Hahn group's investigated this 
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controversy by studying the infrared spectroscopy of diorganocyanocuprate and came to 
the same conclusion as Bertz's group.54  In 1996, Bertz replied to the rhetorical question 
posed earlier by Lipshutz and James by stating "It's on Lithium!" and therefore suggested a 
more conventional formula, modified Gilman like species R2CuLi.LiCN (figure 7b).55 In 1998, 
with the support of 13C, 6Li, 15N NMR and crystallographic (EXAFS) data, Bertz ended the 
controversy of cyano Gilman reagent and concluded that the cyano was not bound to the 
copper.56  
"Lower order" cyanocuprates exist as two main analogues, the symmetric complexes 
(R2CuLi) that results from the dissociation of the "higher order" cyanocuprates (see Figure 
8b)  also called Gilman reagents and unsymmetrical complexes (RCu(CN)Li)  which result 
from the addition of one equivalent of RLi reagent to one equivalent of CuCN. 
Unsymmetrical "lower order" cyanocuprates have been investigated by Bertz using 13C NMR 
spectroscopy  and those studies showed that at −110 °C the coupling between the methyl 
and the cyanide carbon group of 13CH3Cu(13CN)Li  had a value of 21 Hz which could only be 
the case if both groups were bound to the same copper atom.57 These unsymmetrical 
"lower order" cyano-cuprate complexes were found to be useful in 1,4 additions with α,β-
unsaturated ketones, and halide displacement from alkyl halides, since the products of 
these reactions were obtained in improved yields compared to the ones reported with the  
symmetrical "lower-order" cyano-cuprate complex.58 Lithium diorganocopper(I) species 
(R2CuLi) are thermally unstable and thus are prepared at low temperatures. Because of their 
low basicity, diorganocuprates provide alkylation reactions with a variety of organic 
electrophiles, via SN2 and SN2' reactions. Several structures have been proposed for 
diorganocopper(I) species. It can appear as a linear free organocuprates: [R2Cu]− 63, where 
the lithium has been sequestrated from the cluster by mixing R2CuLi with 12-crown-4 
solution, which also strongly decelerates the carbocupration reaction. The Li(I) cation and 
one of the two negative methyl groups are placed in such a fashion from each other that 
they cannot enjoy favorable electrostatic interaction due to the lack of permanent dipole 
making the cuprate unreactive in many standard organocopper reactions. 59 R2CuLi 64 is 
formed upon coordination of a pair of lithium cations to the linear R-Cu-R anion and an 
alkyl, phenyl, methyl group that results in a dimerization of RLi and R2CuLi.60 (R2CuLi)2 65 
exists predominantly as a dimer in solution which has been suggested to have a cyclic 
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structure consisting of an alkyl (or aryl) groups bridging a copper and a lithium atom. This 
structure has been established by NMR spectroscopy and crystallography.61 
 
Scheme 12: Possible "lower- order" organocuprate structures 
 
1.5.2. Molecular orbital descriptions of organocopper reagents 
The nucleophilic organocopper(I) reagents contain a filled set of d orbitals, with two 
perpendicular nodal planes that intersect along the internuclear axis. The linear d orbital of 
copper is more likely to involve an electron pair in a high energy due to the repulsion, hence 
giving a bent structure to the copper(I) reagent. The simplest representation of the reaction 
between organocopper reagents and an electrophile is an orbital overlap between an allylic 
or an alkene orbital and a copper- centred orbital which can be regarded as the result of the 
interaction of a copper d orbital (HOMO) with the LUMO (π*) of the carbons in the carbon-
carbon double bond. This process is commonly called π-backbonding donation due to the 
electron density that is donated from the π-orbital of the ligand to the empty copper d-
orbital to form a ơ like bond and as a consequence, the ligand double bond becomes 
electron deficient which may be remedied by the donation of the copper d-electron pair 
into the empty π* (antibonding) orbital of the ligand, i.e. the π-backbonding aspect. 
(Scheme 13).62 
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Scheme 13: Molecular Orbital representation between a Copper reagent and a ligand  
 
1.5.3. Organocuprate reagents and the use of additives  
The solubility and reactivity of some organocopper reagents in substitution reactions and 
conjugate additions to α,β-unsaturated carbonyl compounds have been investigated. These 
factors are mainly governed by the moderate reactivity of the organocopper reagents or by 
the steric hindrance of the substrates. These issues are often the source of problems when 
low yielding reactions are encountered. In 1977, Yamamoto reported that, upon treatment 
of a neutral organocopper compound with boron trifuoride etherate (BF3•OEt2) at low 
temperature, a reagent was formed with the stoichiometry formula RCu.BF3.63 A few years 
later Yamamoto and Ibuka discovered that AlCl3 could also be used to enhance the reactivity 
of organocopper complexes.64 Following these using Lewis acids (LAs) with some lower-
order cuprates and higher-order cyanocuprate reagents became an effective method for 
improving carbon-carbon bond formation, however other Lewis acids such as ZnCl2, TiCl4 
and SnCl4 were found to be incompatible with high order cuprate reagents due to the 
formation of intractable gum even at low temperature (−78°C) suggesƟng a lack of 
compatibility.65 
 
Scheme 14: equation for the modification of organocopper reagents with boron trifluoride  
 
The reactivity of complexes such as RCu.LA is altered by parameters such as the choice of 
the Lewis Acid (LA=BF3•OEt2, AlCl3, etc.), the choice of solvent (THF, diethyl ether, etc.) the 
choice of copper salt (CuX, where X= Cl, Br, I, CN, etc.) and the stoichiometric amount of 
organometallic reagent (RM, where M= Li or MgX) to CuX.64  
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Conjugate addition reactions of organocuprate reagents to α,β-unsaturated carbonyl 
compound are useful synthetic transformations but the attempted conjugate additions to 
these α,β-unsaturated carbonyl substrates were quite challenging due to poor results 
reported with conventional dialkylcuprate reagents.65 These Lewis acid complexes give an 
efficient conjugate addition to the α,β-enoate esters and α,β-enoic acids affording the 1,4-
alkylated esters and acids in good yields.66 
 
Scheme 15: Conjugate addition to α,β-unsaturated esters and acids  
 
The observation that conjugate addition proceeds well with these Lewis acid activated 
cuprates can be rationalised by a simple mechanistic proposal (Scheme 16). The formation 
of a transition state 73 would involve the coordination of BF3 complex with a carbonyl group 
and therefore trigger the reactivity of the reaction.66 
 
Scheme 16: Formation of the transition state between borontrifluoride and carbonyl substrate  
 
Reactions of alkenes containing electron withdrawing groups with organometallic reagents 
often yield to a complex mixture of products (see for example the reaction of diethyl 
fumarate 74 with n-Bu2CuLi, scheme 15). The AlCl3 complex gives the conjugate adduct, 
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diethyl butylsuccinate (75, 94%), and only a trace amount of the reduced product, diethyl 
succinate (76). However under these same reaction conditions, diethyl maleate 77 yields 
predominantely the reduced form 76 and a small amount of the adduct product 75. This 
difference in reactivity and direction of the reaction path is dependent upon the geometry 
of the double bond of the substrate.67 
 
Scheme 17: Difference in the reactivity of electron deficient alkenes with organocopper(I) Lewis acid reagents 
 
The synthesis of perhydrohistrionicotoxin is an example in which a ϒ-oxygenated α,β-
unsaturated ketone undergoes efficient 1,4-addition with organocopper(I) Lewis acid 
reagents to produce a butyrated ketone. Ordinary organocopper(I) reagents such as (R2CuLi) 
proved to be unsuccessful with this enone and formed undesired side products. Treatment 
of substrate 78 with reagents such as MeCu(CN)Li and Ph2CuLi  yielded none of the desired 
adducts. On the other hand, treatment of 78 with organocopper(I) Lewis acid reagent n-
BuCu•AlCl3 proceeds in a synthetically acceptable yield to give the expected 1,4- 
adducts.68,69,70 
 
Scheme 18: Addition to α,β-unsaturated ketone 
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Reagent Yield Products ratio 
MeCu(CN)Li 0 % 79 0:0 80 
Ph2CuLi 0 % 83 0:0 84 
MeCu•AlCl3 76%   79 92:8 80 
n-BuCu•AlCl3 77%   81 93:7 82 
n-BuCu•BF3 75%   81 100:0 82 
PhCu•AlCl3 69%   83 100:0 84 
 
Table 2: Effect of different organocopper reagents on the enone 59 
Organocopper Lewis acid complexes are the alkylating reagents of choice in SN2' reactions 
with allylic substrates. As illustrated in Scheme 19 for the pair of allylic halides 85 and 88, 
the butyl group is attacking the ϒ-position with a high regioselectivity and in excellent 
yield.71 
 
 
Scheme 19: SN2' Substitution reaction outcomes from allylic chlorides  
(E)-ϒ-mesyloxy-α,β-enoates 91, a promising intermediate derived from tartrates, reacts with 
organocyanocopper•BF3 reagents providing a highly efficient synthesis of divinylmethanol 
derivatives. THF or mixed solvents involving THF are usually preferred so that completion of 
the reaction is achieved within a short period of time  even at −78 °C.72 
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Scheme 20: Organocopper-Lewis acid complex in the (E)-stereoselective reaction of divinylmethanol derivatives 
 
 
Research Outline  
The aim of this project is to contribute to the design and implementation of an organoiron 
controlled stereoselective total synthesis of the alkaloid (+/−)-hippeastrine. Recent work 
within the Stephenson group has demonstrated that chiral alkaloids such as lycoramine and 
mesembrine can be obtained via arylation of a substituted cyclohehexadienyliron 
complexes, hence cyclohexadienyliron complexes are established as a potent stereocontrol 
electrophiles to address stereochemical issues encountered in other alkaloids synthetic 
methods.27 
The subsequent arylation with a cyclohexadienyliron complex with an electron withdrawing 
group (-COOMe) was previously studied but still remains challenging. We seek synthetically 
to use such organometallic reagents in key steps in order to design new routes to related 
alkaloids show-casing the 1,2-iterative strategy to complement the now well-established 
1,1-iterative approaches. Such a strategy should help us to obtain good regio-/ sterocontrol. 
The methods developed in the racemic series can later be employed with more advanced 
enantiomerically pure intermediates. 
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Scheme 21: Proposed synthetic route 
 
Scheme 21 shows how organoiron method used in the proposed synthetic route to (+/−)-
hippeastrine (107 and 108). The plan for the synthesis starts with a convenient published73 
access route to the dienoic ester 95 by the formation of the Wittig salt, (3-
methoxycarbonylallyl)-triphenylphosphonium bromide (94) followed by a tandem Wittig-
Michael addition to obtain the cyclohexadiene methyl ester (95). This cyclohexadiene 
methyl ester (95) may then be treated with Fe2(CO)9 or a transfer reagent to produce the ƞ4 
complex 96. The next stage is the hydride abstraction of 96 with triphenylcarbenium 
hexafluorophosphate to form the highly electrophilic cation 97. Treatment of the ƞ5 species 
97 with the organocuprate formed from 6-bromopiperonylic acid (98) (by treatment with n-
butyllithium and Cu(I)) produced 99. The reaction should occur at the more reactive carbon 
site, reacting at the less hindered end of the π-system on the complex. Once produced, 99 
goes through a series of functional group manipulations to install the two carbon side-chain 
needed later to build the D ring (see Scheme 19 step 100 to 102). Treatment of 103 with the 
aqueous base sodium hydrogen carbonate to produce, the carboxylate anion, cyclise by 
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addition to the least hindered end of the cation π complex and form the B ring (104). The 
next stage in the synthesis would be an heterocycloaddition using a nitroso derivative in the 
presence of trimethylamine N-oxide. This step induces the removal of the ƞ4  tricarbonyliron 
group from 104 and produces the free diene 105.74 This step provides an efficient cis-
selective method to introduce the C–N and C–O substituents on the C ring. The 
cycloaddition to be both regio- and diastereoselective. For the required diastereselectivity, 
nitroso group has to approach the diene from the opposite face of the lactone ring (ring B) 
either by steric control (addition on the unsubstituted side) or by precoordination to the 
iron (after loss of CO by oxidation with TMNO during decomplexation).74 The N-O bond is 
then cleaved using aluminium amalgam strips to generate 106 before forming ring D. 
Reaction of 106 with the catalyst dihydridotetrakis(triphenylphosphine)ruthenium(II) would 
then finally provide our desired alkaloid (+/−)-hippeastrine (107 and 108). 
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2.Results and Discussion 
 
2.1. Aims 
This project aims to develop a pathway towards the synthesis of hippeastrine from the 
Wittig salt substrate. This will be achieved by completing the following steps: 
1. Synthesis of the diene ester cation (97), starting from the phosphonium salt (94), 
followed by a tandem Wittig-Michael addition step, and then iron complexation and 
hydride abstraction to form the highly electrophilic cation. 
2. Determination of the most appropriate organocopper and organolithium reagents and 
reaction conditions to form our desired building block (ABC ring) towards the synthesis 
of hippeastrine. 
 
 
Scheme 22: Synthetic route towards the formation of a "building block" 
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2.2.  Formation of cyclic diene 
2.2.1. Synthesis of  3-ethoxycarbonylallyl-triphenylphosphonium bromide (94) 
In order to begin to synthesise our first intermediate (94), we followed the procedure of 
Gradén et al.73 (3-Methoxycarbonylallyl)-triphenylphosphonium bromide (94) was prepared 
by reacting triphenylphosphine with methyl 4-bromocrotonate 93 in toluene and the 
reaction was stirred for two days. The pure material was isolated as a white powder in 99% 
yield. Confirmation of the formation of the phosphonium salt was drawn from the 1H NMR 
spectrum (the 1H NMR spectrum showed a large aromatic area of fifteen protons that 
characterised the three benzene rings attached to the phosphorus atom and the 
characteristic singlet at 3.63 ppm. that corresponds to the methyl ester peak). 
 
Scheme 23: Formation of 3-methoxycarbonylallyl-triphenylphosphonium bromide  
A proposed mechanism is presented showing how the salt was formed from methyl 4-
bromocrotonate and triphenylphospine through a nucleophilic substitution reaction (SN2).  
 
 
Scheme 24: Proposed mechanism for the formation 3-methoxycarbonylallyl-triphenylphosphonium bromide  
 
2.2.2 Synthesis of cyclohexa-1,3-dienecarboxylic acid methyl ester (95) 
With our (3-methoxycarbonylallyl)-triphenylphosphonium bromide (94) in hand, we started 
the synthesis of the required cyclohexa-1,3-dienecarboxylic acid methyl ester (95) which is 
the backbone for the tricarbonyliron electrophile. A search of the literature revealed a 
protocol for the cyclisation of the diene methyl ester: treatment of (3-methoxycarbonylallyl-
triphenylphosphonium bromide (94) with acrolein in the presence of saturated sodium 
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bicarbonate and dichlomethane.73 A colourless oil was obtained in 51 % yield. The yield 
obtained in this procedure is significantly less than the yield reported by Gradén's research 
group (83 %).73 The 1H NMR spectrum of 95, however, fitted the one reported in the 
literature.73 
MeO
O
PPh3
Br
acrolein
NaHCO3, DCM
rt, 3 days
51%
O
OMe
94 95  
Scheme 25: Formation of Cyclohexa-1,3-dienecarboxylic acid methyl ester 
                                                                                                                                                                                                          
The first step of the reaction is initiated by a Michael addition by the Wittig reagent 
generated from (3-methoxycarbonylallyl)-triphenylphosphonium bromide (94). Sodium 
bicarbonate is used as the base to form the ylide which then reacts with acrolein to form the 
intermediate 111. Tautomerisation of the enol ether leads to 112. Deprotonation triggers an 
intramolecular Wittig reaction affording the desired fused cyclohexadiene methyl ester 
product 95. In 114, both the oxygen anion and the phosphonium cation are located at cis 
position, favouring the syn-elimination of triphenyl phosphine oxide. A detailed mechanism 
waits for further investigation. This is a concerted reaction as bonds are breaking and 
forming in a single step. 
 
Scheme 26: Mechanism for the formation of cyclohexa-1,3-dienecarboxylic acid methyl ester 
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2.3. Tricarbonyliron complexation to cyclohexa-1,3-dienecarboxylic acid methyl ester (96) 
2.3.1. Synthesis of ƞ4 methyl ester complex  
The organoiron approach, discussed previously  in the introduction, provides a valuable 
approach to functionalised cyclohexadiene systems. A review of the literature revealed a 
number of protocols for the formation of the methyl ester tricarbonyl complex. 
We opted to follow a modified synthetic route that Gradén et al.73 used towards the 
synthesis of tricarbonyl(cyclohexa-1,3-dienecarboxylic acid)iron(0) to obtain our desired 
product. In order to obtain tricarbonyl(cyclohexa-1,3-dienecarboxylic acid methyl ester) iron 
(0), we first needed to reflux 95 with diironnonacarbonyl in THF. At 68°C, the temperature 
was high enough to affect the conjugation to the diene. The ease of synthesis and use of 
inexpensive reagents offset the disappointingly low yield. The progress of the reaction was 
monitored by IR spectroscopy, with the product having a pair of strong metal carbonyl 
bands at 2051 and 1975 cm-1. 
 
Scheme 27: Formation of tricarbonyl (cyclohexa-1,3-dienecarboxylic acid methyl ester)iron(0) 
 
However, other approaches described in the literature were also examined. For example 
one method uses the isomerisation of the complexes, tricarbonyl -2-
methoxycarbonylcyclohexa-1,3-dieneiron (115) and tricarbonyl-5-
methoxycarbonylcyclohexa-1,3-dieneiron (116) to form our desired product 96 (Scheme 
28). The mixture of complexes was refluxed for 24 hours in methanol containing sulfuric 
acid, followed by a diethyl ether and ice water work-up.75 The only major issue in this 
reaction is the preparation of isomers, which is lengthy and expensive, hence we chose not 
to follow this route. 
 
34 
 
 
Scheme 28: Formation of tricarbonyl (cyclohexa-1,3-dienecarboxylic acid methyl ester)iron(0) through isomerisation of a 
set of complex  
Another approach which has been reported in the literature is the acidic methanolysis of 
tricarbonyl-5-cyanocarbonylcyclohexa-1,3-dieneiron. Arthur J. Birch et al.76 used a 
procedure in which the nitrile complex 117 was treated in the same way as the method 
discussed previously. This procedure has been shown to be very effective; excellent yields 
was obtained (i.e. 80 %).76 The proposed mechanism of the reaction is illustrated below 
(Scheme 29). The mechanism is initiated by protonation of the nitrile, followed by a 
nucleophilic addition of methanol, subsequent acidic hydrolysis of 121 leads to the 
formation of 127 and a final isomerisation gives desired 96. 
 
Scheme 29: Proposed mechanism for the formation of tricarbonyl (cyclohexa-1,3-dienecarboxylic acid methyl 
ester)iron(0) using the starting material tricarbonyl-5-cyanocarbonylcyclohexa-1,3-dieneiron  
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2.3.2 Formation of the ƞ5 salt  
 The next step was the formation of the tricarbonyliron cation 97 by hydride abstraction 
using the condition described by Fischer.77 Treatment of 96 with triphenylcarbenium 
hexafluoropshate (Ph3C⁺PF6⁻) in dichloromethane at room temperature overnight resulted 
in the formation of the cation with a hexafluorophosphate counter anion (Scheme 30).  
 
 
Scheme 30: Formation of Tricarbonyl(ŋ5 -carboxylic acid methyl ester) iron (1+) hexafluorophosphate (1-) 
Cyclohexa-1,3-dienecarboxylic acid methyl ester gives 97 as the only isolatable product. Due 
to the steric demand of the methyl ester group, the hydrogen atom at the 5-position is the 
less hindered hence hydride abstraction will be favoured at this position.78 
2.4. Preparation of 6-bromopiperonylic acid  
2.4.1. Canizzaro reaction 
6-Bromopiperonylic acid (98) is readily available from chemical suppliers but unfortunately 
it is costly. A search in the literature provided a few different routes. Fales et al. was the first 
procedure that we considered for the synthesis of 6-bromopiperonylic acid (98). The 
method is based on the Cannizzaro reaction of 6-bromopiperonal (128).79 Unfortunately the 
reaction did not work; neither of the two compounds were recovered which was indicated 
by 1H NMR spectroscopy. Moreover, considering that a Cannizarro reaction would give at 
best a 50% yield, we moved on without further studying this reaction. 
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Scheme 31: Mechanism of the Cannizzaro reaction of 6-bromopiperonal 
2.4.2 KMnO4 oxidation 
Another approach which has received large attention to afford 6-bromopiperonal80 is the 
oxidation of 6-bromopiperonal using potassium permanganate. 
 
Scheme 32: Formation of 6-bromopiperonylic acid 
In this case, we were rewarded with success. The 1H NMR spectrum of the product obtained 
matched the one reported in literature.80 Methylene protons were observed at 6.15 ppm. 
(lit. 6.07 ppm.), the two protons on the phenyl ring were observed at 7.29 ppm. for the one 
adjacent to the bromine unit and 7.31 p.p.m. for the one adjacent to the carboxylic acid 
group (lit. 7.34 and 7.54 ppm.). The carboxylic acid proton was observed at 13.14 ppm. (lit. 
11.0 ppm.). The final product is highly hygroscopic and it was kept in a desiccator filled with 
phosphorus pentoxide as dehydrating agent. 
2.5. Aryl addition to tricarbonyl(ŋ5-carboxylic acid methyl ester) iron (1+) 
hexafluorophosphate(1−) 
Nucleophilic addition to cationic (cyclohexadienyl) iron complexes is well established and 
previous studies within the Stephenson group have found a route to hippeastrine using 
organocuprate reagents.81 Scheme 33 illustrates the addition of 6-bromopiperonylic 
derivatives 98, 132, 133 (using copper(I) bromide and an aryllithium reagent) to the ƞ5 salt 
37 
 
97. The nucleophile is generated by the addition of n-butyllithium (two equivalents were 
needed for the compound 98  and 1.2 equivalents were needed for compounds 132 and 
133) followed by the addition half of an equivalent amount of the copper(l) bromide. The 
reaction was cooled down to a temperature of -78 °C and left to stir for two hours. Once the 
organocuprate was formed, the ƞ5 salt 97 was added in a single portion. The reaction 
mixture instantaneously changed colour.  
 
Scheme 33: General preparation method for the addition of nucleophiles to cationic (cyclohexadienyl)iron complex 
 
Several attempts to generate compound 99 using the methodology presented in scheme 33 
were made. Formation of nucleophile 98 was attempted, using n-butyllithium for the 
transmetallation, followed by addition of half of an equivalent of copper(I) bromide. 
However, upon addition of the salt, no trace of the expected product was observed. 
Discussion of this issue will be presented in the following paragraphs. Copper(I) bromide is 
highly hygroscopic which could have caused problems in the reaction but remained our 
preferred reagent compared to copper(I) cyanide that is more toxic. Metalation at the 
ortho-position of arylcarboxylic acid can be achieved because of additional activation 
provided by the methylenedioxy moiety, therefore the deprotonation of this position could 
lead to the formation of by-products. 
As explained previously the nucleophilic addition of the salt to 6-bromopiperonylic acid 
raised few issues. The lack of product could be due to: 
1. Presence of water in 6-bromopiperonylic acid which was interfering with the lithiation 
process. 
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2. Problem with the deprotonation / lithium halogen exchange 
3.  Problem in the organocuprate formation 
To avoid wasting tricarbonyl(ŋ5-carboxylic acid methyl ester)iron(1+) hexafluorophosphate,  
we used deuterium oxide (D2O) as the electrophile to investigate the metalation problem 
encountered with 6-bromopiperonylic acid before the addition of the ƞ5 salt.  
2.5.1. Metalation and deuteration of 2-bromobenzoic acid 
We started with the simple 2-bromobenzoic to investigate the lithium-halogen exchange 
followed by deuteration process. Once the reaction was fully completed, its 1H NMR 
spectrum was obtained and compared with 2-bromobenzoic acid and the simple benzoic 
acid to determine the percentage of deuterium incorporation at the ortho-position of 
benzoic acid. The first method implied the addition of n-butyllithium to a solution of 2-
bromobenzoic acid in THF at −78 °C. The reacƟon was leŌ to sƟr at −78 °C for two hours 
followed by an addition of D2O (10 equivalents). The reaction was then finally quenched 
with 1M HCl and the aqueous phase was extracted with dichloromethane (this is to ensure 
that none of the compounds formed in the reaction are obtained as salts which would affect 
the NMR and would prevent the comparison with SM and simple dehalogenated 
compound). 
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Figure 8: 1H NMR stack of deuterated benzoic acid, 2-bromobenzoic acid and benzoic acid 
 
Figure 9: 1H NMR of deuterated benzoic acid in method 1 
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Figure 10: Benzoic acid and deuterated 2-bromobenzoic acid protons labelling  
This stack of 1H NMR (Figure 8) shows the comparison of the deuterated product 137 (red) 
with the starting material 2-bromobenzoic acid (blue) and benzoic acid (136, this would be 
the product obtained by quench of the lithiobenzene derivative by a proton source, see 
Figure 8 in green) in the region of interest (from 7.35 ppm to 8.05ppm). It can be observed 
(Figure 9) that 7% of the starting material is present in the product (0.16/(0.16 +1.99)= 
0.07= 7% of starting material). Hc is present in both 136 and 137, therefore it can be used as 
a reference, and the integration of Hc from 136 and 137 has been set as 2 in Figure 9 acid 
wash spectrum. The difference of the integral of our "reference" protons Hc with the 
integral of proton Hb allowed us to obtain the percentage of deuterium incorporation. In 
this method the integral of Hc is equal to two and the integral of Hb is 1.47 (2.00 −1.47 = 
0.53). By this method we calculated a 53% incorporation of deuterium. If we neglect the 7% 
of 2-bromobenzoic acid remaining in this reaction, 47% of benzoic acid was obtained from 
lithiated 2-bromo benzoic acid which means there was a significant proton source in this 
reaction mixture. We thought that perhaps, the bromine-lithium exchange could be faster 
than the deprotonation of the carboxylic acid (which could sound surprising considering the 
low pKa of benzoic acid) which would explain the large proton incorporation. To test this 
idea we moved on to another substrate, 5-methoxy-2-bromobenzoic acid, which would be a 
better model for the expensive/precious 2-bromopiperonylic acid.  
 Method 1 
Deuterated benzoic acid 53 % 
Benzoic acid 47 % 
Table 3: Percentage deuterium incorporation and side product present in each method  
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2.5.2. Metalation and deuteration of 5-methoxy-2-bromobenzoic acid  
5-Methoxy-2-bromobenzoic acid was lithiated and deuterated. Method 2 involved the 
addition of LiHMDS at 0 °C over a ten minutes period followed by the addition of n-
butyllithium at −78 °C and the reaction was stirred for two hours at this temperature and 
was quenched with D2O. In method 3, NaH was added to the starting material at −78 °C and 
was warmed up at room temperature. The reaction was cooled back to −78 °C at which 
point n-butyllithium was added and the reaction was stirred for one hour and then 
quenched with D2O. In method 4, methyllithium was added to the starting material at −78 
°C and the reaction was warmed up to −40 °C. The reacƟon was cooled back to −78 °C 
followed by the addition of n-butyllithium, after which the reaction was stirred for one hour 
and was quenched with D2O. For every reaction completed, the 1H NMR spectrum of the 
crude product was compared with the ones of 5-methoxy-2-bromobenzoic acid and 3-
methoxybenzoic acid to determine the percentage of deuterium incorporation in each 
reaction. 
 
Figure 21: 1H NMR stack of deuterated 3-methoxybenzoic acid,5-methoxy-2-bromobenzoic acid and 3-methoxybenzoic 
acid using Method 2 
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Figure 12: 1H NMR for lithiated and deuterated 3-methoxybenzoic acid in the region of interest 
 
 
Figure 13: 3-methoxybenzoic acid and deuterated 3-methoxybromobenzoic acid protons labelling  
 
Figure 11 shows the 1H NMR of our lithiated and deuterated product 139 in method 2(red) 
with the starting material 5-methoxy-2-bromobenzoic acid 140 (blue) and 3-
methoxybenzoic acid 138 (green) of the region of interest (from 7.00 ppm to 7.60 ppm). To 
obtain our percentage deuteration, we know the integral of Ha + Ha' to 1 (at 7.44 ppm). Then 
we subtract from this the integration corresponding to proton Hd present in the 3-
methoxybenzoic acid (multiplet between 7.55-7.52 ppm) which integrates with a value of 
0.24 therefore 1-0.24= 0.76 meaning 76% of deuterium incorporation if we neglect the 
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starting material. Integration of the doublet at 7.26 ppm (starting material) gave 11% SM 
(0.12/1.12) . Overall we have 11% SM, 21% (0.24/1.12= 0.21) of 3-methoxybenzoic acid and 
finally 68% (0.76/1.12= 0.68) of the deuterated product 139. The same method was used to 
calculate the deuteration percentage in each reaction (see Experimental section for a full 
reaction method). 
 Method 2 Method 3 Method 3 Method 4 
5-methoxy-2-
bromobenzoic acid 
 
11 % 
 
33 % 
 
16 % 
 
71 % 
3-methoxybenzoic acid  
21 % 
 
37 % 
 
13 % 
 
26 % 
Deuterated 3-
methoxybenzoic acid  
 
68 % 
 
28 % 
 
71 % 
 
3 % 
Table 4: Percentage of deuterium incorporation and side product  present in each method   
Overall, Table 4 is showing positive results for method 2 and 3. This is probably showing us 
that the proton of the carboxylic acid was quenching the reaction. 
 
Scheme 34: Lithiation and quenching of deuterated 3-methoxybenzoic acid 
Scheme 34 is a proposed experiment that would prove that when using n-butyllithium, the 
bromine-lithium exchange is faster than the deprotonation of the carboxylic acid, which 
would then quench the reaction. 
2.5.3. Metalation and deuteration of 6-bromopiperonylic acid  
In order to save the precious 6-bromopiperonylic acid, we performed the deuterium quench 
experiment to optimise the reaction.  
6-Bromopiperonylic acid was lithiated and deuterated. Method 5 employed two equivalents 
of n-butyllithium at −100 °C. The reacƟon was sƟrred for one hour followed by the addiƟon 
of D2O at −100 °C. In Method 6, 1.2 equivalents of LiHMDS were added to the starting 
material 98 over a period of ten minutes (see Experimental section for more time details) 
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followed by the addition of n-butyllithium. The reactions were stirred for different times and 
were quenched with deuterium oxide. Method 7 involved the addition of NaH to 6-
Bromopiperonylic acid (98) at −78 °C and then reacƟons were allowed to warm to room 
temperature for thirty minutes. This was followed by the addition of n-butyllithium at −78 °C 
and reactions were stirred at various times (see Experimental section for time details) and 
were quenched with D2O. In method 8, methyllithium was added to the starting material 98 
at −78 °C and the reacƟon was warmed to −40 °C. The reacƟon was cooled back to −78 °C 
followed by the addition of n-butyllithium and the reaction was then stirred for one hour 
and was quenched with D2O.  
For every reaction completed, the 1H NMR of the reaction was compared with those of 6-
Bromopiperonylic acid and piperonylic acid to determine the percentage of deuterium 
incorporation in each reaction. 
 
Figure 14: 1H NMR stack of deuterated piperonylic acid, 6 -bromopiperonylic acid and piperonylic acid using method 5 
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Figure 14 shows a stack of 1H NMR that compare our lithiated and deuterated product 149 
(red) with the starting material 6-bromopiperonylic acid 98 (blue) piperonylic acid 148 
(green) in the region of interest (from 6.85 ppm to 7.65 ppm) using method 5. It can be 
observed that a mixture of different compounds is present in the product. Other than 
starting material 98, piperonylic acid and our deuterated product, another outcome was 
observed in our 1H NMR. Deuteration also happened at the 2-position 150 (Figure 16) that is 
due to addition of one equivalent of n-butyllithium hence exchanging bromine for lithium. 
The lithium is exchanged for the acidic proton which then after addition of the second 
equivalent of n-butyllithium deprotonate and lithiate at the 2-position 
 
Scheme 35: Possible lithiation position after addition of two equivalent of n-butyllithium 
 
 
Figure 16: protons labelling of the different outcomes obtained in the lithiation and deuteration process of 6-
bromopiperonylic acid 
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Figure 17: Deuteriation experiment of 95 using method 5: aromatic region of the 1H NMR spectrum  
 
 
The proton NMR spectrum shows a mixture of products 95, 148 and 149 and 150. In order 
to calculate the percentage deuteriation (we will first omit the SM), we will use the only 
proton not affected by the lithiation being Ha (signal at 6.99 ppm) as our reference and set 
its integral to 1. The integration of the signal at 7.54 ppm (0.76) gives us the percentage 
deuteriation at the d position (149, 24%), and the integral of the signal at 7.35 ppm (0.87) 
gives us the percentage deuteriation at the b position (150, 13%). When we account for the 
presence of unreacted starting material (Ha’ and Hb’ both individually integrate for 1.4), we 
obtain the following proportions: 58% of 98 [1.4/(1.4+1) = 0.58], 26% of 148 [(1-0.13-
0.24)/(1+1.4) = 0.26), 10% of 149 [0.24/(1+1.4) = 0.10] and 5% of 150 [0.13/(1+1.4) = 0.05]. 
The same reasoning was used to acquire percentage deuteriation using other methods. (see 
Experimental section) 
 
0.
26
1.
00
1.
41
1.
39
0.
87
0.
76
6.
98
43
6.
99
10
7.
00
06
7.
28
28
7.
30
64
7.
35
31
7.
35
65
7.
53
10
7.
53
44
7.
54
73
7.
55
06
47 
 
Table 5: Percentage of deuterium incorporation and side product  present in method 6 
Table 5 is showing different entries. Entries 3 and 4 are different attempts using the same 
conditions. Entry 5 exhibits different conditions, after addition of LiHMDS, the reaction was 
stirred at −78 °C for two hours and then warmed up at 0 °C for thirty minutes. The reaction 
was cooled back to −78 °C and n-butyllithium was added and the reaction was stirred for 
two hours at −78 °C and then quenched with HCl followed by D2O. Entry 6 used different 
conditions to entries 1,2 and 3, after addition of LiHMDS, the reaction was stirred at −78 °C 
for one hour and then warmed up at 0 °C for thirty minutes. The reaction was cooled back 
to −78 °C and n-butyllithium was added and reaction was stirred for one hour at −78 °C. The 
reaction was quenched with HCl followed by D2O.  (see experimental section for details). 
 
 
 
 
 
 
 
Table 6 : Percentage of deuterium incorporation and side product  present in method 7 
Table 6 is showing different entries. Entries 7 and 8 are different attempts using the same 
conditions. Entry 9 exhibits different conditions from entries 7 and 8, after addition of NaH, 
the reaction was stirred at −78 °C and then warmed to room temperature. The reaction was 
Method 6 Entry 3 Entry 4 Entry 5 Entry 6 
 
95 
 
5 % 
 
1 % 
 
6% 
 
26 % 
 
147 
 
30 % 
 
44 % 
 
28 % 
 
8 % 
 
148 
 
41 % 
 
16 % 
 
15 % 
 
10 % 
 
146 
 
24 % 
 
39 % 
 
51 % 
 
54 % 
Method 7 Entry 7 Entry 8 Entry 9 
 
95 
 
72 %  
 
91 %  
 
31 % 
 
147 
 
22 % 
 
 
5 % 
 
 
3 % 
 
 
148 
 
2 % 
 
1 % 
 
12 % 
 
146 
 
4 % 
 
2 % 
 
53 % 
48 
 
cooled back to −78 °C and n-butyllithium was added and reaction was stirred for ten 
minutes at −78 °C. This was followed by a temperature rise and the reacƟon was sƟrred 
between −40 to −20 ˚C  for one hour and half. The reacƟon was quenched with HCl followed 
by the addition of D2O.  
 
 
 
 
 
 
 
 
   Table 7: Percentage of deuterium incorporation and side product  present in method 4 
Table 7 is showing different entries. Both entries are using same temperature conditions but 
the time that the reaction was left to stir after the addition of methyllithium is altered. (see 
experimental section for details). 
 Conclusion for the deuteration experiments: 
All these deuteriation experiments showed that either method 2, method 4 and method 6 
were the best, giving at best 47 % deuteriation using 98, but also 68 % deuteriation using 
140. When omitting the recovered starting materials (98 or 140), the best percentage 
deuteriation were obtained using method 2. 
2.6. Arylation results using improved method for the metalation of arylbromide starting 
materials 
Considering the results previously obtained in the deuteriation experiments, we chose to 
use method 1 (a Schlenk line was used this time during the entire reaction process, flushing 
nitrogen gas) to form the lithium salt. This lithium salt would then be transformed to a 
Method 8 Entry 10 Entry 11 
 
95 
 
16 % 
 
35 % 
 
147 
 
47 % 
 
19 % 
 
148 
 
3 % 
 
33 % 
146 33 % 12 % 
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cuprate using the method of Stephenson82 which would then be reacted with cation 97 
(Scheme 36). The results of the arylations are shown in Table 8 and are described below. 
 
Scheme 36: Improved arylation reaction 
 
 
 
 
 
 
 
 
 
 
 
 
Table 8: Arylation results  
Reaction of tricarbonyl(ŋ5-carboxylic acid methyl ester)iron(1+) hexafluorophosphate (97) 
with the cuprate salt of  4-bromo-1,2(methylenedioxy)benzene (132) at −78 °C , gave a dark 
yellow oil. Chromatography on silica removed any impurities to give the pure tricarbonyl 
[ŋ4-1-methyl ester-5-(3',4'-methylenedioxy)phenylcyclohexa-1,3-diene]iron(0) (134) in 19% 
yield as a brown-yellow oil. The yield was disappointing but would most likely have been 
improved by repeating the reaction more carefully, which was however not possible due to 
the lack of time.  
Another arylation using compound 133 that presents a bulkier R substituent (which was 
prepared in two steps). First, 3,4-methylenedioxybenzyl alcohol was brominated with N-
Ar Product Yield (%) 
 
 
134 
 
19 
 
135 
 
0 
 
 
99 
 
27 
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bromosuccinimide giving 2-bromo-4,5-ethylenedioxybenzyl alcohol (151) as a white solid 
(95 % yield). This product reacted with pyridinium p-toluenesulfonate and  3,4-dihydro-2H-
pyran affording 2-bromo-4,5-methylenedioxybenzyl 1-tetrahydropyranyl ether (152)83 in 
89% yield. From 133, the organocuprate nucleophile was prepared using method 1 for the 
lithiation and then adding copper(I) bromide; tricarbonyl(ŋ5-carboxylic acid methyl 
ester)iron(1+) hexafluorophosphate was added to the nucleophile. However 
chromatographic purification proved to be difficult and the different fractions recovered 
were evaporated. 1H NMR of these fractions were performed in chloroform and no 
recognisable proton signals are present that is inexplicable to us.  
Finally, tricarbonyl[ŋ4-1-methyl ester-5-(3',4'-methylenedioxy-6'-carboxyphenyl)cyclohexa-
1,3-diene]iron(0) (99) was obtained in 27% yield from 98 and 97 using method 1 for the 
lithiation. The proton NMR of 99 was complex due to the presence of diastereoisomers 
which complicates the 1H NMR spectrum by doubling resonances. The methoxy signal is the 
simplest still significant example that can be used to explain this phenomenon. Indeed, at 
3.72 ppm, two peaks are present which integrate three protons for each peak. 
Conclusion 
In summary, we have successfully synthesised tricarbonyliron cation 97 in 72% yield. We 
also investigated the metalation problem encountered with 6-bromopiperonylic acid (98) 
and the ƞ5 salt by using deuterium oxide as an electrophile with 98 and compounds with 
similar physical properties (2-bromobenzoic acid and 5-methoxy-2-bromobenzoic acid. Our 
desired tricarbonyl[ŋ4-1-methyl ester-5-(3',4'-methylenedioxy-6'-carboxyphenyl)cyclohexa-
1,3-diene]iron(0) (99) was successfully synthesised in 27% yield using method 1. Compound 
132 and 133 underwent metalation with the tricarbonyliron cation 97 to give 134 and 135 in 
19% and 0% yield respectively. The synthesis of these compounds could be optimised by 
having a better control of reaction conditions, use of different copper sources /different 
cuprates such as the use of CuCN. In the future, we would try to optimise these step and 
carry on the synthesis towards hippeastrine. Once a robust route to various analogues of 
hippeastrine has been developed, further work would concentrate on obtaining 
hippeastrine in a non-racemic fashion. This work is actually ongoing in our laboratories using 
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an enantiopure chiral cationic iron salt to introduce the desired stereochemistry in the final 
compound. 
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3.Experimental  Section  
 
General Methods. Chemicals of reagent grade were used as purchased unless stated 
otherwise. When mentioned as distilled, THF and Et2O were freshly distilled from sodium 
benzophenone ketyl. DCM and acetonitrile were distilled from calcium hydride. Toluene was 
distilled from sodium. All non-aqueous reactions were carried out under oxygen-free 
nitrogen or argon using flame-dried glassware. Organolithium reagents were titrated 
according to the procedure reported by Burchat84, using N-benzylbenzamide. Flash column 
chromatography was carried out using Davisil LC60A 40-63 micron silica (amorphous silicon 
dioxide). Thin layer chromatography was carried out using commercially available 
Macherey-Nagel pre-coated TLC-sheets (ALUGRAM® SIL G/UV254 silica plates). Microwave 
experiments were run with a Biotage Initiator Robot Sixty. Proton and carbon NMR spectra 
were recorded on a Bruker Avance III 500 MHz spectrometer with a 5 mm broad band 
observe BBFOplus smart probeTM fitted with an actively shielded z-gradient coil (500 MHz). 
NMR signals were measured using the residual non-deuteriated NMR solvent signal as a 
reference (for 1H NMR, CHCl3 at 7.27 ppm and DMSO at 2.50 ppm). For 13C NMR, CDCl3 at 
77.0 ppm and DMSO-d6 at 39.51 ppm were used. Melting points were measured on a Buchi 
melting point B-545 apparatus. Infra-red spectra were recorded on a Perkin Elmer Spectrum 
100 FT-IR spectrometer. Chemical ionisation and high resolution mass spectra were 
measured at the EPSRC Mass Spectrometry Centre at the University of Wales, Swansea. 
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3.1. Preparation of (3-methoxycarbonylallyl)triphenylphosphonium bromide 73 (94) 
 
 
 
Methyl 4-bromocrotonate 93 (17.1 mL, 0.12 mol) was added dropwise to a solution of 
triphenylphosphine (32.0 g, 0.12 mol) fully dissolved in toluene (200 mL). The reaction 
mixture was stirred at room temperature for 2 days, forming a white precipitate. This white 
precipitate was collected by filtration, washed with toluene and diethyl ether and dried 
under vacuum to afford the product as white crystals 94 (52.4 g, 99%). 1H NMR (500 MHz, 
CDCl3) δ 7.66 – 7.89 (m, 15H), 6.72 (td, J= 13.9, 7.6 Hz 1H), 6.47 (dd, J = 15.5, 4.9 Hz, 1H), 
5.25 (ddd, J= 16.4, 7.6, 1.2 Hz, 2H), 3.65 (s, 3H).  13C NMR (126 MHz, CDCl3) δ 165.4 (d, JC-P = 
2.8 Hz), 135.3 (d, JC-P = 3.0 Hz), 134.0, 133.9, 132.6, 130.6, 130.5, 130.4, 130.3, 130.2, 129.0, 
117.9, 117.2, 51.8, 27.9 (JC-P = 51 Hz). IR (NaCl) ʋ 2857, 1717, 1436, 1111 cm-1  
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3.2. Preparation of cyclohexa-1,3-dienecarboxylic acid methyl ester 73 (95) 
 
 
 
(3-Methoxycarbonylallyl)triphenylphosphonium bromide 94 (52.4 g, 0.12 mol) was dissolved 
in dichloromethane (928 mL) followed by the addition of saturated hydrogen sodium 
bicarbonate (742 mL) and acrolein (7.9 mL, 0.12 mol). The reaction mixture was stirred at 
room temperature for 3 days and the two distinct layers were separated and the organic 
phase was evaporated under reduced pressure to form a red/ orange oil. The oil was 
dissolved in a small amount of dichloromethane, evaporated on silica gel and then eluted 
through a silica column using dichloromethane as the solvent system to give a colourless oil 
95 (8.5 g, 51.3 %), Rf: 0.67, 1H NMR (500MHz, CDCl3) δ 6.97 – 6.99 (dd, J= 5.4, 0.9 Hz, 1H), 
6.10 – 6.15 (m, 1H), 6.01 – 6.07 (ddt, J= 9.3, 5.4, 1.9 Hz, 1H), 3.74 (s, 3H), 2.41 – 2.47 (tt, 
J=10.4, 2.8 Hz, 2H), 2.22 – 2.28 (m, 2H), 13C NMR (126MHz, CDCl3) δ 167.9, 133.5, 133.2, 
127.1, 123.9, 51.5, 22.8, 20.7, IR (NaCl) ʋ 2952, 1715, 1683, 1436, 1268 cm-1 
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3.3. Preparation of tricarbonyl(cyclohexa-1,3-dienecarboxylic acid methyl ester)iron(0)73 
(96) 
 
 
 
 
Diiron nonacarbonyl (51.5 g, 0.14 mol) was introduced into a round bottomed flask and 
nitrogen was flushed through, then dry THF (76.4 mL) was added until a slurry is formed. 
Cyclohexa-1,3-dienecarboxylic acid methyl ester 95 (8.5 g, 0.06 mol) dissolved in THF (25.2 
mL) was added to the slurry. The reaction mixture was flushed one more time with nitrogen 
and stirred at 68 °C for 5 hours. The mixture was passed through a sinter funnel filled with 
Kieselguhr and washed with diethyl ether. Silica gel was added to the filtrate which was then 
evaporated under reduced pressure and purified by silica gel column chromatography 
(petroleum ether/EtOAc, 80:20) to afford  96 as a yellow oil (5.28 g, 32 %). Rf= 0.75, 1H NMR 
(500 MHz, CDCl3) δ 6.04 (s, 1H), 5.36 (s, 1H), 3.70 (s, 3H), 3.37 (s, 1H), 2.17 (t, J= 12.5 Hz, 1H), 
1.92 (t, J= 13.0 Hz, 1H), 1.69 (d, J= 12.9 Hz, 1H), 1.44 (d, J= 10.4 Hz, 1H). 13C (126 MHz, CDCl3) 
δ 210.2, 172.6, 133.5, 123.9, 88.4, 64.6, 51.6, 25.1, 22.8, IR (NaCl) ʋ 2951, 2052, 1977, 1712 
cm-1 
 
 
 
 
 
 
 
OMe
O
Fe(CO)3
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3.4. Preparation tricarbonyl(ŋ5 -carboxylic acid methyl ester)iron(1+) hexafluorophosphate 
(1−)77 (97) 
 
 
 
Triphenylcarbenium hexafluorophosphate (12.7 g, 0.03 mol) was dissolved in a minimum 
volume of dichloromethane (40 mL) under nitrogen atmosphere. The tricarbonyl(cyclohexa-
1,3-dienecarboxylic acid methyl ester)iron(0) 96 (6.5 g, 0.02 mol) which had previously been 
prepared was also dissolved in a minimum amount of dichloromethane (15 mL) under 
nitrogen atmosphere and was slowly poured into the triphenylcarbenium 
hexafluorosphosphate solution. The resulting dark mixture was stirred overnight at room 
temperature and was slowly added to diethyl ether (165 mL). A bright yellow precipitate 
formed and was collected by filtration and washed with diethyl ether and dried under 
vacuum to afford yellow solid  (7.1 g, 72%). 1H NMR (500 MHz, CD3CN) δ 7.30 (s, 1H), 6.56 
(d, J = 5.1 Hz, 1H), 5.89 (s, 1H), 4.70 (t, J= 6.3 Hz, 1H), 3.82 (s, 3H), 3.28 (dd, J= 15.5, 6.3 Hz, 
1H), 1.91 (d, J=15.5 Hz, 1H). 13C (126 MHz, CD3CN) δ 209.2, 117.9, 104.7, 102. 5, 90.7, 71.6, 
53.9, 23.9, IR (NaCl) ʋ 2123, 2064, 1721 cm-1. 
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3.5. Preparation of 6- bromopiperonylic acid79 (98) 
 
O
O
Br
O
OH
 
 t-BuOH (60 mL) and water (150 mL) were added to 6-bromopiperonal (6.0 g, 0.03 mol) and 
the mixture was heated to reflux at 83 oC. When the reaction mixture achieved this 
temperature, a solution of potassium permanganate (4.0 g, 0.03 mol) in water (75 mL) was 
poured in over a period of 45 minutes. The reaction mixture turned brown and was refluxed 
overnight at 83 oC and then a solution of 10% potassium hydroxide (30 mL) was added to 
the warm brown suspension which raised the pH to 10-11. The suspension was filtered and 
the filtrate was extracted with diethyl ether (4 × 100 mL). The colourless aqueous layer was 
acidified with concentrated HCl (12 mL) to precipitate a white chalky solid 98 which was 
collected by filtration and dried under vacuum over phosphorus pentoxide (1.76 g, 27 %), 
m.p.: 206-208 °C (lit, mp: 203-204 °C)85, 1H NMR (500 MHz, DMSO) δ 13.14 (s, 1H), 7.31 (s, 
1H), 7.29 (s, 1H), 6.15 (s, 2H). 13C (126 MHz, DMSO-d6) δ 166.9, 150.8, 147.4, 126.4, 114.1, 
113.37, 110.7, 103.2, IR (NaCl) ʋ 3410, 1654, 1648 cm-1 
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3.6. General procedure for the preparation of lithiation and deuteration of 2-
bromobenzoic acid 
 
D
OH
O
Br
OH
O
OH
O
136 137  
Method 1: n-Butyllithium (1.6 mol dm-3 solution in hexanes; 0.31 mL, 0.99 mmol) was added 
dropwise to a solution of 2-bromobenzoic acid (0.1 g, 0.49 mmol) in THF (9 mL) at −78 °C 
and the reaction mixture appeared pale yellow. The reaction was stirred for 2 hours and was 
quenched with deuterium oxide (0.1 mL) and was quenched with 1M HCl (17 mL) and the 
aqueous phase was extracted with dichloromethane (3 × 50 mL).The product was obtained 
as a white solid (0.03 g, 57%) which was dried over calcium chloride. The crude was 
characterised . 
137 1HNMR (500 MHz, DMSO) δ 12.93 (s, 1H), 7.96 – 7.93 (m, 1.47H), 7.64 – 7.60 (m, 1H), 
7.52 – 7.48 (m, 2H). 13C NMR (126 MHz, DMSO) δ 169.6, 141.2, 129.5, 128.9, 126.99, 127.9, 
127.5, 127.3 
 Benzoic acid 
136 1H NMR (500 MHz, DMSO),δ 12.93 (s, 1H), 7.96 – 7.93 (m, 2H), 7.64 – 7.50 (m, 1H), 7.52 
– 7.46 (m, 2H). 13C (126 MHz, DMSO) δ 169.6, 141.2, 129.5, 128.9, 127.9, 127.5, 127.3. 
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3.7. General procedure for the preparation of lithiation and deuteration of 2-bromo-5-
methoxy benzoic acid 
 
 
 Method 2: LiHMDS (2.00 mL, 2.00 mmol) was added to a solution of 2-bromo-5-methoxy 
benzoic acid (0.5 g, 2.00 mmol) in THF (30 mL) over a 10 min period. The  reaction was 
warmed at 0 °C then cooled back at −78 °C, then n- butyllithium (1.6 mol dm-3 solution in 
hexanes; 2.5 mL, 4.00 mmol) was added dropwise. The reaction was stirred for 2 hours then 
deuterium oxide was added (0.10 mL). The reaction was quenched with 1M HCl (17 mL) and 
the aqueous phase was extracted with dichloromethane (3 × 50 mL) and dried under 
vacuum to afford the crude as a white solid (0.068 g).  
2-Bromo-5-methoxbenzoic acid 
140 1H NMR (500 MHz, DMSO) δ 13.01 (s, 1H), 7.58 (d, J = 8.8 Hz, 1H), 7.26 (d, J = 3.2 Hz, 
1H), 7.02 (dd, J = 8.8, 3.2 Hz, 1H), 3.80 (s, 3H). 13C NMR (126 MHz, DMSO) δ 167.6, 159.7, 
132.6, 130.1, 122.0, 119.4, 114.3, 55.7.  
5-Methoxybenzoic acid  
138 1H NMR (500 MHz, DMSO) δ 13.01 (s, 1H), 7.55-7.52 (m, 1H), 7.44 (d, J = 2.7 Hz, 1H), 
7.41 (t, J = 8.2 Hz, 1H), 7.19 (dd, J = 8.3, 2.7 Hz, 1H), 3.80 (s, 3H). 13C NMR (126 MHz, DMSO) 
δ 167.6, 159.7, 130.1, 122.0, 119.4, 114.3, 55.7. (Yield, 22 %) 
Deuterated 2-bromo-5-methoxy benzoic acid 
139 1H  NMR (500 MHz, DMSO) δ 13.01 (s, 1H), 7.44 (d, J = 2.7 Hz, 1H), 7.41 (t, J = 8.2 Hz, 
1H), 7.19 (dd, J = 8.3, 2.7 Hz, 1H), 3.80 (s, 3H). 13C NMR (126 MHz, DMSO) δ 167.6, 159.7, 
132.6, 130.1, 122.0, 119.4, 116.07 114.3, 55.7. (Yield, 63%) 
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Method 3: NaH (0.05 g, 2.00 mmol Entry: 1; 0.10 g, 4.00 mmol Entry 2) was added to a 
solution of 2-bromo-5-methoxy benzoic (0.46 g, 2.00 mmol) in THF (30 mL) at −78 °C. A 
white precipitate formed. The reaction mixture was allowed to warm up at room 
temperature and a white precipitate disappeared. Once the reaction mixture reached room 
temperature, it was cooled to −78 °C and then n-butyllithium (1.6 mol dm-3 solutions in 
hexanes; 1.25 mL, 2 mmol) was added dropwise.  The reaction was stirred for 1 hour and 
deuterium oxide was added (0.10 mL). The reaction was quenched with 1M HCl (17 mL) and 
the aqueous phase was extracted with dichloromethane (3 × 50 mL).  
Entry 1  
White solid (0.287 g). 
2-Bromo-5-methoxy-benzoic acid 
140 1H NMR (500 MHz, DMSO) δ 13.13 (s, 1H), 7.58 (d, J = 8.8 Hz, 1H), 7.26 (d, J = 3.2 Hz, 
1H), 7.02 (dd, J = 8.8, 3.2 Hz, 1H), 3.80 (s, 3H).  
5-Methoxy-benzoic acid  
138 1H NMR (500 MHz, DMSO) δ 13.13 (s, 1H), 7.54– 7.51 (m,1H), 7.44 (d, J = 2.0 Hz, 1H), 
7.41 (t, J = 8.3 Hz, 1H),  7.18 (dd, J = 8.3, 2.7 Hz, 1H), 3.80 (s, 3H). 
Deuterated 2-bromo-5-methoxy benzoic acid 
139 1H NMR (500 MHz, DMSO) δ 13.13 (s, 1H), 7.44 (d, J = 2.0 Hz, 1H), 7.41 (t, J = 8.3 Hz, 1H), 
7.18 (dd, J = 8.3, 2.7 Hz, 1H), 3.80 (s, 3H).  
Entry 2:  
White solid (0.281 g). 
2-Bromo-5-methoxy benzoic acid 
140 1H NMR (500 MHz, DMSO) δ 13.04 (s, 1H), 7.58 (d, J = 8.8 Hz, 1H), 7.26 (d, J = 3.2 Hz, 
1H), 7.02 (dd, J = 8.8, 3.2 Hz, 1H), 3.80 (s, 3H).  
5-Methoxy-benzoic acid  
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138 1H NMR (500 MHz, DMSO) δ 13.04 (s, 1H), 7.54– 7.51 (m,1H), 7.44 (d, J = 2.0 Hz, 1H), 
7.41 (t, J = 8.3 Hz, 1H),  7.18 (dd, J = 8.3, 2.7 Hz, 1H), 3.80 (s, 3H). 
Deuterated 2-bromo-5-methoxy benzoic acid 
139 1H NMR (500 MHz, DMSO) δ 13.04 (s, 1H), 7.44 (d, J = 2.0 Hz, 1H), 7.41 (t, J = 8.3 Hz, 1H), 
7.18 (dd, J = 8.3, 2.7 Hz, 1H), 3.80 (s, 3H).  
Method 4: Methyllithium (1.6 mol dm-3 solution in diethyl ether; 2.02 mL, 3.24 mmol) was 
added to a solution of 2-bromo-5-methoxy benzoic (0.5 g, 2.16 mmol) in THF (30 mL) at −78 
°C. The reaction mixture turned pale yellow. The reaction mixture was allowed to warm up 
at −40 °C for a period of (15-30 min). Once the reaction mixture reached −40 °C, it was 
cooled back to −78 °C and then n-butyllithium (1.6 mol dm-3 solution in hexanes; 1.35 mL, 
2.16 mmol) was added dropwise and the solution turned orange / dark yellow. The reaction 
was stirred for 1 hour and appeared yellow and deuterium oxide was added (0.10 mL). The 
reaction was quenched with 1M HCl (17 mL) and the aqueous phase was extracted with 
dichloromethane (3 × 50 mL). The product was obtained as a white solid (0.283 g ).  
 2-Bromo-5-methoxy benzoic acid 
140 1H NMR (500 MHz, DMSO) δ 13.29 (s, 1H), 7.58 (d, J = 8.8 Hz, 1H), 7.26 (d, J = 3.2 Hz, 
1H), 7.02 (dd, J = 8.8, 3.2 Hz, 1H), 3.80 (s, 3H).  
5-Methoxy-benzoic acid  
138 1H NMR (500 MHz, DMSO) δ 13.29 (s, 1H), 7.54 – 7.52 (m ,1H), 7.44 (d, J = 2.5 Hz, 1H), 
7.41 (t, J = 8.3 Hz, 1H),  7.18 (dd, J = 8.0, 2.3 Hz, 1H), 3.80 (s, 3H). 
Deuterated 2-bromo-5-methoxy benzoic acid  
 139 1H NMR (500 MHz, DMSO) δ 13.29 (s, 1H), 7.44 (d, J = 2.0 Hz, 1H), 7.41 (t, J = 8.3 Hz, 
1H), 7.18 (dd, J = 8.0, 2.3 Hz, 1H), 3.80 (s, 3H).  
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3.8. General procedure for the preparation of lithiation and deuteriation of 6-
bromopiperonylic acid  
 
 
Method 5: n- butyllithium (1.6 mol dm-3 solution in hexanes; 2 equivalents) was added 
dropwise to a solution of 6-bromopiperonylic acid (1 equivalent) in THF (20 mL) at −100 °C. 
The reaction was stirred for various times and deuterium                     
oxide was added (0.10 mL). The reaction was quenched with 1M HCl (17 mL) and the 
aqueous phase was extracted with dichloromethane (3 × 50 mL). The crude appeared as a 
white solid (0.10 g)  
149 1H NMR (500 MHz, DMSO) δ 12.96 (s, 1H), 7.35 (s, 1H), 7.00 (d, J = 8.1 Hz, 1H), 6.15 (s, 
2H).  
150 1H NMR (500 MHz, DMSO) δ 12.96 (s, 1H), 7.55 (d, J = 8.1 Hz,  1 H), 7.00 (d, J = 8.1 Hz, 
1H), 6.15 (s, 2H).  
148 1H NMR (500 MHz, DMSO) δ 12.96 (s, 1H), 7.55 (d, J = 8.1 Hz,  1 H), 7.35 (s, 1H), 7.00 (d, 
J = 8.1 Hz, 1H), 6.15 (s, 2H).  
Method 6: LiHMDS (1.2 equivalents Entry 3, Entry 4, Entry 5, 1.1 equivalents Entry 6) was 
added over a 10 min period at various temperatures, then n- butyllithium (1.6 mol dm-3 
solution in hexanes; 2 equivalent) was added dropwise to a solution of 6- bromopiperonylic  
acid (1 equivalent ) in THF (30 mL). The reaction was stirred for various times deuterium 
oxide was added (0.10 mL). The reaction was quenched with 1M HCl (17 mL) and the 
aqueous phase was extracted with dichloromethane (3 × 50 mL). 
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Entry temperature time 
Entry 3 
Brown/yellow solid 
0.122 g 
LiHMDS at −78 °C, 
warm at 0 °C, 
deuteriation and 
lithiation at −78 °C 
1 hr 
30 min 
2 hrs 
Entry 4 
Brown/yellow solid 
0.174 g 
LiHMDS at −78 °C, 
warm at 0 °C, 
deuteriation and 
lithiation at −78 °C 
1hr 
30 min 
2hrs  
Entry 5 
Brown/ yellow solid 
0.014 g 
LiHMDS at −78 °C, 
warm at 0 °C, 
deuteriation and 
lithiation at −78 °C 
 2 hr 
30 min 
2 hr 
Entry 6 
Brown/yellow solid  
0.059 g 
LiHMDS at −78 °C, 
warm at 0 °C, 
deuteriation and 
lithiation at −78 °C 
1 hr 
30 min 
1 hr 
 
Deuterated product- Entry 3 
149 1H NMR (500 MHz, DMSO) δ 12.75 (s, 1H), 7.35 (s, 1H), 7.00 (d, J = 8.2 Hz, 1H), 6.15 (s, 
2H).  
150 1H NMR (500 MHz, DMSO) δ 12.75 (s, 1H), 7.55 (d, J = 8.15 Hz, 1 H), 7.00 (d, J = 8.2 Hz, 
1H), 6.15 (s, 2H).  
148 1H NMR (500 MHz, DMSO) δ 12.75 (s, 1H), 7.55 (d, J = 8.15 Hz,  1 H), 7.35 (s, 1H), 7.00 
(d, J = 8.2 Hz, 1H), 6.15 (s, 2H).  
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Deuterated product- Entry 4 
149 1H NMR (500 MHz, DMSO) δ 12.74 (s, 1H),  7.35 (s, 1H), 7.00 (d, J = 8.2 Hz, 1H), 6.14 (s, 
2H).  
150 1H NMR (500 MHz, DMSO) δ 12.74 (s, 1H), 7.55 (d, J = 8.2 Hz, 1H), 7.00 (d, J = 8.2 Hz, 
1H), 6.14 (s, 2H).  
148 1H NMR (500 MHz, DMSO) δ 12.74 (s, 1H), 7.55 (d, J = 8.2 Hz, 1H), 7.35 (s, 1H), 7.00 (d, J 
= 8.2 Hz, 1H), 6.14 (s, 2H).  
Deuterated product- Entry 5 
149 1H NMR (500 MHz, DMSO) δ 12.74 (s, 1H),  7.35 (s, 1H), 7.00 (d, J = 8.2 Hz, 1H), 6.14 (s, 
2H).  
150 1H NMR (500 MHz, DMSO) δ 12.74 (s, 1H), 7.54 (d, J = 8.2 Hz, 1H), 7.00 (d, J = 8.2 Hz, 
1H), 6.14 (s, 2H).  
148 1H NMR (500 MHz, DMSO) δ 12.74 (s, 1H), 7.54 (d, J = 8.2 Hz, 1H), 7.35 (s, 1H), 7.00 (d, J 
= 8.2 Hz, 1H), 6.14 (s, 2H).  
deuterated product- Entry 6 
149 1H NMR (500 MHz, DMSO) δ 12.84 (s, 1H),  7.35 (s, 1H), 7.00 (d, J = 8.2 Hz, 1H), 6.14 (s, 
2H).  
150 1H NMR (500 MHz, DMSO) δ 12.84 (s, 1H), 7.55 (d, J = 8.2 Hz, 1H), 7.00 (d, J = 8.2 Hz, 
1H), 6.14 (s, 2H).  
148 1H NMR (500 MHz, DMSO) δ 12.84 (s, 1H), 7.55 (d, J = 8.2 Hz, 1H), 7.35 (s, 1H), 7.00 (d, J 
= 8.2 Hz, 1H),  6.14 (s, 2H).  
Method 7:  NaH (0.05 g, 2 mmol Entries 7 and 8; 0.10 g, 4 mmol Entry 9) was added to a 
solution of 6-bromopiperonylic acid (0.25 g, 1 mmol Entries 7 and 8 ; 0.49 g, 2 mmol Entry 
9) in THF (30 mL) at different temperature. A white precipitate formed. The reaction mixture 
was allowed was allowed to cool down at −78 °C and then n-butyllithium (1.6 mol dm-3 
solution in hexanes; 1.25 mL, 2 mmol) was added dropwise. The reaction was stirred 
65 
 
(various times and temperatures) and deuterium oxide was added. The reaction was 
quenched with 1M HCl (17 mL) and the aqueous phase was extracted with dichloromethane 
(3 × 50 mL). 
Entry Temperature Time 
Entry 7 
White/ yellow solid 
0.5 g  
NaH at −78 °C,  
warm at  r.t, 
deuteriation and 
lithiation at −78 °C 
1 min 
30 min 
2hrs 
Entry 8 
Brown solid  
0.129 g 
NaH at −78 °C,  
warm at  r.t, 
deuteriation and 
lithiation at −78 °C 
1 min 
30 min 
2hrs 
Entry 9 
Yellow solid  
0.031 g 
NaH at −78 °C,  
warm at  r.t, 
lithiation at −78 °C, 
warm the reaction 
between −40 to −20 
°C, 
deuteriation at −78 
°C 
1 min 
30 min 
10 min 
1hr 30 min 
 
 
Few seconds 
 
Deuterated product- Entry 7 
146 1H NMR (500 MHz, DMSO) δ 13.02 (s, 1H),  7.35 (s, 1H), 7.00 (d, J = 8.2 Hz, 1H),  6.14 (s, 
2H).  
147 1H NMR (500 MHz, DMSO) δ 13.02 (s, 1H), 7.55 (d, J = 8.2 Hz,  1 H), 7.00 (d, J = 8.2 Hz, 
1H), 6.14 (s, 2H).  
145 1H NMR (500 MHz, DMSO) δ 13.02 (s, 1H), 7.55 (d, J = 8.2 Hz, 1 H), 7.35 (s, 1H), 7.00 (d, J 
= 8.2 Hz, 1H), 6.14 (s, 2H).  
deuterated product- Entry 6 
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149 1H NMR (500 MHz, DMSO) δ 13.03 (s, 1H), 7.35 (s, 1H), 7.00 (d, J = 8.2 Hz, 1H), 6.14 (s, 
2H).  
150 1H NMR (500 MHz, DMSO) δ 13.03 (s, 1H), 7.55 (d, J = 8.2 Hz, 1H), 7.00 (d, J = 8.2 Hz, 
1H), 6.14 (s, 2H).  
148 1H NMR (500 MHz, DMSO) δ 13.03 (s, 1H), 7.55 (d, J = 8.2 Hz, 1H), 7.35 (s, 1H), 7.00 (d, J 
= 8.2 Hz, 1H), 6.14 (s, 2H). 
 Deuterated product- Entry 7 
149 1H NMR (500 MHz, DMSO) δ 11.61 (s, 1H), 7.35 (s, 1H), 7.00 (d, J = 8.2 Hz, 1H), 6.14 (s, 
2H).  
150 1H NMR (500 MHz, DMSO) δ 11.61 (s, 1H), 7.55 (d, J = 8.2 Hz, 1H), 7.00 (d, J = 8.2 Hz, 
1H), 6.14 (s, 2H).  
148 1H NMR (500 MHz, DMSO) δ 11.61 (s, 1H), 7.55 (d, J = 8.2 Hz, 1H), 7.35 (s, 1H), 7.00 (d, J 
= 8.2 Hz, 1H), 6.14 (s, 2H).  
Method 8: Methyllithium (1.6 mol dm-3 solutions in diethyl ether; 1.53 mL, 2.45 mmol) was 
added to a solution of 6-bromopiperonylic acid (0.4 g, 1.63 mmol) in THF (30 mL) at - 78˚C. 
The reaction mixture was stirred (various temperatures and times). Once the reaction 
mixture reached the desired temperature, it was cooled back to -78 ˚C and then n-
butyllithium (1.6 mol dm-3 solution in hexanes; 1.35 mL, 2.16 mmol) was added dropwise. 
The reaction was stirred for various times, followed by a deuterium oxide addition (0.10 
mL). The reaction was quenched with 1M HCl (17 mL) and the aqueous phase was extracted 
with dichloromethane (3 × 50 mL). 
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Entry Temperature Time 
Entry 10 
White solid  
0.286 g 
MeLi at −78 °C,  
deuteriation and 
lithiation at −78 °C 
10 min 
1 hr 
 
Entry 11 
White solid 
0.214 g 
MeLi at -78 °C,  
deuteriation and 
lithiation at −78 °C 
4 hrs 
1 hr 
 
Deuterated product- Entry 10 
149 1H NMR (500 MHz, DMSO) δ 12.71 (s, 1H), 7.35 (s, 1H), 7.00 (d, J = 8.0 Hz, 1H), 6.11 (s, 
2H).  
150 1H NMR (500 MHz, DMSO) δ 12.71 (s, 1H), 7.55 (d, J = 8.15 Hz, 1 H), 7.00 (d, J = 8.0 Hz, 
1H), 6.11 (s, 2H).  
148 1H NMR (500 MHz, DMSO) δ 12.71 (s, 1H), 7.55 (d, J = 8.15 Hz, 1 H), 7.35 (s, 1H), 7.00 (d, 
J = 8.0 Hz, 1H), 6.11 (s, 2H).  
Deuterated product- Entry 11 
149 1H NMR (500 MHz, DMSO) δ 12.64 (s, 1H), 7.35 (s, 1H), 7.00 (d, J = 8.15 Hz, 1H), 6.11 (s, 
2H).  
150 1H NMR (500 MHz, DMSO) δ 12.64 (s, 1H), 7.54 (d, J = 8.15 Hz, 1 H), 7.00 (d, J = 8.15 Hz, 
1H), 6.11 (s, 2H).  
148 1H NMR (500 MHz, DMSO) δ 12.64 (s, 1H), 7.55 (d, J = 8.15 Hz, 1 H), 7.35 (s, 1H), 7.00 (d, 
J = 8.15 Hz, 1H), 6.11 (s, 2H).  
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3.9. Preparation of tricarbonyl [ŋ4-1-methyl ester-5-(3',4'-
methylenedioxy)phenylcyclohexa- 1,3-diene]iron(0)81 (134) 
 
 
 
 
n- Butyllithium (2.5 mol dm-3 solution in hexanes; 1.19 mL, 2.98 mmol) was added dropwise 
to a solution of 4-bromo-1,2-(methylenedioxy)benzene (132) (0.30 mL, 2.48 mmol) in THF 
(40 mL) at −78 °C and the reaction mixture appeared pale yellow. The mixture was stirred 
for 2 hours at −78 °C and then CuBr (0.18 g, 1.24 mmol) was added and the reaction 
appeared brown. After the mixture had been stirred for a further 10 minutes, its 
temperature was allowed to rise to −40 °C at which point the substrate tricarbonyl(ŋ5 -
carboxylic acid methyl ester) iron (1+) hexafluorophosphate (1−) (0.68 g, 1.07 mmol) was 
added and the mixture became dark brown. The mixture was warmed to 0 °C and turned 
black. The reaction was quenched with 2M HCl (17 mL). The aqueous phase was extracted 
with diethyl ether (3 × 50 mL) to give a dark yellow residue after drying and solvent removal. 
Column chromatography on silica gel with diethyl ether / hexane (1:10) afforded the title 
compound. (0.19 g, 19 %). 1HNMR (500 MHz, CDCl3) δ 6.67 (d, J = 7.8 Hz, 1H, 3'- and 5'-H ), 
6.59 – 6.54 (m, 2H, 6'-H), 6.24 (d, J = 4.0 Hz, 1H, 2-H), 5.90 (s, 2H, OCH2O), 5.46 (dd, J = 6.3, 
4.5 Hz, 1H, 3-H), 3.71 (s, 3H, OMe), 3.42 (dt, J = 11.4, 3.7 Hz, 1H, 5-H), 3.28 (ddd, J = 6.2, 3.3, 
1.1 Hz, 1H, 4-H), 2.77 (dd, J = 11.4, 11.5 Hz, 1H, 6β-H), 1.44 (dd, J = 15.5, 4.0 Hz, 1H, 6α-H). 
13C NMR (126 MHz, CDCl3) δ 209.85 (s, Fe(CO)3), 172.3 (C=O), 147.8 (s, 4'- or 3'-C), 146.1 (s, 
3'- or 4'-C), 140.00 (s, 2-C), 120.0 (s, 6'-C) 108.1 (s, 5'- or 2'-C), 106.9 (s, 2'- or 5'-C), 100.9 (s, 
OCH2O), 89.0 (s, 3-C), 84.3 (s, s, 4- or 1-C), 62.7 (s, OMe), 51.7 (s, 1- or 4-C), 45.5 (s, 5-C), 
32.4 (s, 6-C). IR (NaCl) ʋ 2053, 1979, 1233 cm-1, HRMS [M+H]+ Calculated for C18H15FeO7: 
398.01; Found: 399.0162.  
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3.10. Preparation of 2- bromo- 4,5- methylenedioxybenzyl alcohol (151)83  
 
 
 
 
 
3,4-methylenedioxybenzyl alcohol (5 g, 33 mmol) was dissolved in dichloromethane (51 mL) 
and the solution  was cooled in an ice bath. N-Bromosuccinimide (5.85, 33 mmol) was added 
over a period of 20 minutes and the reaction mixture was stirred for 2 hours at 5 °C. 10% 
aqueous sodium sulphite (1.29 M, 25.5 mL) was added and the two layers were stirred for 5 
min. The organic phase was separated from the aqueous layer. The aqueous layer was 
washed with dichloromethane (2×51 mL) and the organic phases were combined and dried 
over anhydrous sodium sulfate and the solvent was removed under reduced pressure to 
give the white solid 2-bromo-4,5-methylenedioxybenzyl alcohol 151 (7.2 g, 95%). 1H NMR 
(500 MHz, CDCl3) 1H NMR (500 MHz, CDCl3) δ 6.99 (s, 1H), 6.97 (s, 1H), 5.97 (s, 2H), 4.63 (s, 
2H), 2.75 (s, 1H), 13C NMR (126 MHz, CDCl3) δ 147.80, 147.55, 133.12, 113.02, 112.70, 
109.15, 101.79, 64.93. IR (NaCl) ʋ 3417, 2901, 1480 cm-1 .  
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3.11. Preparation of 2-bromo-4,5-methylenedioxybenzyl 1-tetrahydropyranyl ether (152) 
83, 86 
 
 
 
 
2- Bromo- 4,5- methylenedioxybenzyl alcohol 151 (7.24 mL, 31 mmol) was dissolved in 
dichloromethane (49 mL), then pyridinium p-toluenesulfonate (8.5 mg, 0.034 mmol) and  
3,4-dihydro-2H-pyran (2.87 mL, 31 mmol) were added. The reaction was stirred overnight at 
room temperature and water (24 mL) was added. The two layers were separated and the 
aqueous phase was extracted with dichloromethane (49 mL). The organic phases were 
combined and the solvent was evaporated at reduced pressure. The compound was 
dissolved in a small amount of dichloromethane, evaporated under reduced pressure on 
silica gel and then eluted through a silica column using hexane / EtOAc (95:5) as the solvent 
system to yield a colourless oil 152 (8.7 g, 89 %). 1H NMR (500 MHz, CDCl3) δ 7.01 (s, 1H), 
6.99 (s, 1H), 5.96 (s, 2H), 4.74 (s, 1H), 4.70 (d, J = 0.4 Hz, 1H), 4.49 (d, J = 12.8 Hz, 1H), 3.95 – 
3.88 (m, 1H), 3.59 – 3.54 (m, 1H), 1.91 – 1.48 (m, 6H), 13C NMR (126 MHz, CDCl3) δ 147.57, 
147.39, 131.08, 113.19, 112.60, 109.27, 101.68, 98.30, 68.49, 62.22, 30.53, 25.45, 19.36, IR 
(NaCl) ʋ 2942, 1479, 1245, 1035 cm-1.  
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3.12. Preparation of tricarbonyl[ŋ4-1-methyl Ester-5-(3',4'-methylenedioxy-6'-
carboxyphenyl) cyclohexa- 1,3-diene]iron(0)81 (99) 
 
 
 
 
n- butyllithium (2.5 mol dm-3 solution in hexanes; 0.8 mL, 2 mmol) was added dropwise to 6-
bromopiperonylic acid (0.5 g, 1 mmol) in THF (40 mL) at −78 °C and the reacƟon mixture 
appeared yellow. The mixture was stirred for 2 hours at −78 °C and then CuBr (0.07 g, 0.5 
mmol) was added and the reaction remained yellow. After the mixture had been stirred for 
a further 10 minutes, its temperature was allowed to rise to −40 °C at which point the 
substrate tricarbonyl (ŋ5 -carboxylic acid methyl ester) iron (1+) hexafluorophosphate (1−) 
(0.12 g, 0.47 mmol) was added and the mixture became brown. The mixture was warmed to 
0 °C and was still brown. The reaction was quenched with 2M HCl (17 mL). The two phases 
were separated and the aqueous phase was extracted with diethyl ether (3 × 50 mL). The 
organic layers were combined to give a dark yellow residue after drying over magnesium 
sulfate, filtration and solvent removal under reduced pressure. Column chromatography on 
silica gel eluted  with diethyl ether / hexane (1:10) then 4% methanol in DCM afforded the 
title compound. (0.12 g, 27 %). 1H NMR (500 MHz, CDCl3) δ 7.63 (d, J = 8.3 Hz, 1H), 7.41 (s, 
1H, ArH), 6.75 (s, 1H, ArH), 6.74 – 6.72 (m, 1H), 6.26 (d, J = 4.0 Hz, 1H, 2-H), 6.21 (d, J = 4.1 
Hz, 1H, 2-H), 6.06 (d, J = 1.3 Hz, 1H, O-CH2-O), 6.02 (d, J = 1.4 Hz, 1H, O-CH2-O), 6.01 (d, J = 
1.3 Hz, 1H, O-CH2-O), 5.99 (d, J = 1.3 Hz, 1H, O-CH2-O), 5.52 (dd, J = 6.3, 4.4 Hz, 1H, 3-H), 5.40 
(dd, J = 6.3, 4.5 Hz, 1H, 3-H), 4.68 (dt, J = 11.3, 3.8 Hz, 1H, 5-H), 4.62 – 4.58 (m, 1H, 5-H), 3.72 
(s, 3H, OMe), 3.72 (s, 3H, OMe), 3.38 – 3.35 (m, 2H), 2.88 (dd, J = 15.5, 11.5 Hz, 1H, 6β-H), 
2.63 (dd, J = 15.0, 11.5 Hz, 1H, 6β-H), 1.72 (dd, J = 15.1, 4.2 Hz, 1H, 6α-H), 1.36 (dd, J = 15.7, 
4.1 Hz, 1H, 6α-H).13C NMR (126 MHz, CDCl3) δ 211.3 (s, Fe(CO)3), 172.5 (C=O of the ester), 
151.6 (C=O of the carboxylic acid), 145.8, 145.6, 145.1, 129.0, 127.5, 122.5, 121.1, 110.6, 
107.1, 106.5, 101.9, 101.5 (O-CH2-O), 88.9, 88.5, 85.1, 84.5, 67.1, 64.9, 62.9, 62.7, 51.6, 40.3, 
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37.4, 31.9, 27.8. IR (NaCl) ʋ 3406, 2953, 2055, 1986, 1704, 1682, 1256 cm-1. HRMS [M+H]+ 
Calculated for C19H14FeO9: 442.0; Found: 443.0073 
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